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I. THE DEVELOPMENT OF 
THE CONCEPT OF CHOLINERGIC TRANSMISSION 
AT PERIPHERAL SYNAPSES 
The nerve or muscle impulse consists of 
a wave of electrical activity, the action 
potential, propagated along the fibre by 'local 
circuit' transmission, and dependent on selective 
permeability to ions of the cell membrane. 
During the early part of this century 
it was considered that this electrical trans- 
mission of the wave of excitation was unbroken 
across nerve -nerve and nerve- effector cell 
junctions. However, there is a difference 
between fibre and synapse - while conduction is 
equally possible in either direction in nerve 
or muscle fibre, transmission across a synapse 
is unidirectional. 
The first suggestion that nervous effects 
might be transmitted by means of a chemical 
stimulant was made by Elliott in 1904. He had 
just showed that adrenaline exhibited effects 
similar to those of stimulation of the sympathetic 
nervous system, acting at the periphery and only 
on muscles which possessed or had possessed 
sympathetic innervation. He suggested that 
there might be a structure on the muscle cell 
whose function was to receive and transform the 
nervous impulse, and that adrenaline might be 
the chemical stimulant liberated when the 
impulse arrived at the periphery (Elliott, 1901#). 
This idea was taken up by Dixon (1906) 
who further suggested that parasympathetic 
nerves might also release a chemical transmitter 
- for example, stimulation of the vagus might 
result in the release of a substance 'inhibitin' 
which caused cardiac standstill. 
However, the idea then lay dormant for 
a period of 15 years. In the interim, Hunt 
and Taveau (1906) tested a number of esters of 
choline, and found one of them, acetylcholine, 
to have 'extraordinary physiological activity'. 
An injection of i ml. of a solution of 1 x 10 9w /v 
acetylcholine caused a fall in the blood pressure 
of a curarised rabbit, and this property made 
it 'the most powerful substance known in effect 
on the circulation'. Also in this period 
Sir Henry Dale was drawn into this field. 
He found acetylcholine in a sample of ergot, and 
was prompted to make a detailed study of its 
action, and that of some other esters of choline 
(Dale, 1911+). He found that acetylcholine 
showed all the characteristics of stimulation of 
the parasympathetic nervous system (muscarine- 
like properties), and also possessed nicotine - 
like properties (e.g. stimulation of sympathetic 
ganglia). Its effects were transient, and 
he surmised that this was due to its ready 
hydrolysis to choline and acetic acid. However 
it had not been shown to occur in the body, and 
so speculations on its physiological significance 
were not justified. 
Then, in 1921, Loewi performed his 
classical experiment with the perfused frog 
heart. He showed that perfusion fluid taken 
from a heart during inhibition by vagal stimula- 
tion and transferred to another heart would 
cause slowing of this second heart also. Thus 
some 'vague substance' must have been released 
by the vague nerve in the first heart, there to 
act on the cardiac muscle (Loewi, 1921). This 
was followed by a series of experiments in which 
he showed that this transmitter had the 
u 
properties of an unstable ester of choline, 
which was rapidly destroyed by an esterase 
present in heart muscle. The action of the 
transmitter, but not its release, could be 
prevented by atropine, and its destruction by 
the esterase could be prevented by eserine. 
Thus it had been shown that parasympathetic 
effects could be transmitted by a substance 
which showed all the properties of acetylcholine 
- but acetylcholine had never been demonstrated 
as a natural body constituent. Then in 1929 
Dale and Dudley succeeded in isolating and 
identifying acetylcholine from horse and ox 
spleen (Dale and Dudley, 1929). The release 
of a substance resembling acetylcholine by other 
parasympathetic nerves was also demonstrated 
e.g. the chorda- lingual nerve, by observing 
the effect of stimulating it on the denervated 
tongue, which has become sensitised to acetyl- 
choline (Dale and Gaddum, 1930), and the vagus 
nerve to the stomach, by taking venous effluent 
from the perfused stomach and subjecting it to 
parallel assays against known acetylcholine 
solutions (Dale and Feldberg, 1934a). The sum 
of this evidence made it quite clear that at 
5. 
post -ganglionic parasympathetic nerve- endings, 
a chemical transmitter was released, and that 
this transmitter was acetylcholine (Dale, 1934). 
It had long been known that there were 
a few sites at which sympathetic stimulation was 
not mimicked by adrenaline, the best known 
example being the sweat- glands of man and the 
cat. Dale and Feldberg (1934b) showed (by 
perfusing the foot with eserinised Locke's 
solution and testing the effluent) that for the 
sweat glands of the pads of the cat's foot, the 
transmitter was acetylcholine. In the previous 
year, Dale had suggested the terms ' cholinergic' 
and 'adrenergic' for fibres, since he said that 
chemical transmission at parasympathetic and 
sympathetic nerve endings was generally accepted, 
though the actual identities of the transmitters 
were not known (Dale, 1933). This work of 
Dale and Feldberg showed that there could be, 
in some instances, cholinergic sympathetic fibres. 
Chang and Gaddum (1933) tested extracts 
from many animal tissues for acetylcholine. 
They confirmed the earlier finding of large 
amounts in horse and ox spleen and also found 
human placenta to be rich. in acetylcholine, 
without being able to explain these high 
results. Generally, they found that tissues 
with highest acetylcholine- equivalents were 
those tissues whose main activities were 
controlled by nerves which could be supposed 
to act by liberating acetylcholine. They also 
found fairly large amounts in horse sympathetic 
chain - acetylcholine was known. to stimulate 
ganglia, and so could it be involved in normal 
transmission at ganglia? 
Kibjakow (1933) perfused the superior 
cervical ganglion of a cat with Lockets 
solution and found that perfusote collected 
during a period of stimulation of the pre- 
ganglionic sympathetic nerve, when added again 
to the perfusion fluid, would itself stimulate 
the ganglion, as shown by a contraction of the 
nictitating membrane. He suggested that there 
was a chemical transmitter released at the 
ganglionic synapse. 
Feldberg and Gaddum (1934), using the same 
technique, could not repeat Kib jakow's results, 
but found that if eserine was added to the 
Lockets solution perfusion fluid, the perfusate 
%, 
collected during preganglionic stimulation 
showed acetylcholine -like activity, while 
perfusate collected before or after stimulation 
was inactive. The active substance was 
indistinguishable from acetylcholine in parallel 
quantitative biological assays. Feldberg, 
Minz and Tsudzimura (1934) stimulated the 
splanchnic nerves of a cat and demonstrated 
salivary secretion and effects on its blood 
pressure due to released acetylcholine, as well 
as effects of the adrenaline liberated from the 
cells of the adrenal medulla. Thus the 
splanchnic nerve fibres were shown to release 
acetylcholine as their transmitter substance, 
and these fibres are also preganglionic 
sympathetic fibres, the adrenal medullary cells 
being morphologically equivalent to sympathetic 
ganglion cells. Feldberg and Vartiainen (1934) 
showed that in the cat superior cervical 
ganglion, the released acetylcholine could only 
have come from the preganglionic nerve -endings, 
and that the output of acetylcholine was 
proportional to the number of stimuli. 
There was ample evidence, then, that 
acetylcholine was released at preganglionic 
synaptic endings, and that it could be synthesised 
during prolonged stimulation in order to 
maintain transmission in the ganglion 
indefinitely (Brown and Feldberg, 1936). But 
unlike the slow, steadily maintained response 
of autonomic structures to nerve stimulation, a 
single preganglionic impulse evokes a single 
postganglionic impulse, so that a ganglionic 
transmitter would have to vanish within the 
refractory period of the cell. It could only 
be said that, in the absence of eserine, no 
acetylcholine could be detected in venous fluid, 
and that there was a high concentration of 
cholinesterase, the specific enzyme known to 
destroy acetylcholine, in the sympathetic 
ganglion, and that this disappeared on degenera- 
tion of the preganglionic nerve (Dale, 1937). 
Finally there remained the neuromuscular 
junction, a rather more awkward proposition for 
perfusion due to the bulk of the muscle fibres 
compared to the tiny, scattered motor nerve - 
endings. Dale, Feldberg and Vogt (1936) did 
however succeed in perfusing various mammalian 
voluntary muscles with eserinised Lockets 
solution, and obtaining active samples only on 
stimulation of the motor-nerves, the active 
substance being indistinguishable from acetyl- 
choline. Acetylcholine was not obtained on 
direct stimulation of denervated muscle, but 
was still obtained during motor nerve stimulation 
when muscle contraction was completely blocked 
by curarine - its appearance was thus associated 
with neuromuscular transmission and not with 
mechanical response. 
The next problem was that normal voluntary 
muscle had never been shown to give quick 
contractions - twitches - in response to acetyl- 
choline. Only slow contractures had been 
observed, in some frog or bird muscles and in 
denervated mammalian muscle (see Dale, 1937). 
Dale thought that the reason for this 
failure was probably the inability to produce 
an abrupt substantial concentration similar to 
that produced by sudden release of acetylcholine 
close to the motor end -plates. Brown, Dale 
and Feldberg (1936) designed a method of 
arterial injection close to the desired muscle 
(cat gastrocnemius) with which they succeeded 
in obtaining quick contractions in response to 
small doses of acetylcholine. These quick 
contractions superficially resembled rather 
slow single twitches, but were, as expected, 
shown by electrical records to be short bursts 
of asynchronous tetanus, produced by summation 
of the asynchronous, repetitive, progagated 
twitches of individual fibres (Brown, 1937). 
Brown also showed that eserine, by delaying the 
destruction of acetylcholine, converted the 
response to a single nerve impulse from a 
single twitch to a repetitive response, a short 
waning tetanus. 
Thus by 1937 it was concluded that trans - 
mission at peripheral synapses was chemical, 
and that the transmitter released from -)re- 
sw.Eo_iC 
ganglionic autonomic nerve -endings, post - 
ganglionic parasympathetic nerve- endings and 
motor nerve -endings was acetylcholine. This 
impinged on the sensitive post- synaptic 
structures and was then quickly removed, by 
diffusion or by a high local concentration of 
the enzyme cholinesterase. The exception 
was the post- ganglionic sympathetic nerve -ending 
11_ 
where the transmitter was an adrenaline -like 
substance (Dale, 1937). This idea of chemical 
transmission was then generally accepted, except 
by J.C. Eccles and some of his colleagues, 
who did not believe that chemical transmission 
took place at ganglia. In 1944, he still 
maintained that in this case transmission was 
due to a direct depolarisation of the ganglion 
cell by the 'action current' of the preganglionic 
impulse, ';iith a 'tail action' due to liberated 
acetylcholine, mainly because he was unable 
to obtain a potentiating effect of eserine on 
potentials set up by preganglionic volleys 
(Eccles, 1944). However, in 1952, he finally 
withdrew this opposition on the basis of 
observations made on motoneurones of the 
mammalian central nervous system (Brock, Coombs 
and Eccles, 1952). 
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II. MICROPHYSIOLOGY OF 
CHOLINERGIC PLRIPHERAL SYNAPSES 
(a) THE NEUROMUSCULAR JUNCTION 
The resting nerve or muscle fibre maintains, 
by steady metabolic activity, concentration 
gradients of sodium and potassium across its 
surface membrane, resulting in a potential 
difference across the membrane. Excitation 
occurs when this potential difference is 
reduced to a critical 'threshold' level, at 
which point there is an alteration in membrane 
permeability and an exchange of ions across 
the membrane, causing a large potential change - 
the 'spike' or 'action potential'. The 
action potential is propagated by 'local 
circuit' transmission, which depends on 
structural continuity of the nerve or muscle 
fibre (Hodgkin, 1951; Castillo and Katz, 1956). 
At the neuromuscular junction, this 
continuity is broken, and, as has been shown 
in the previous section, here transmission is 
effected by release of acetylcholine from the 
motor nerve -endings. This acetylcholine acts 
on special sensitive structures on the muscle 
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fibre, the motor end -plates, causing an action 
potential to be set up, and is subsequently 
destroyed by the enzyme cholinesterase. 
Technical developments, mainly in the use of 
electro- physiological methods, have enabled 
further details of this process to be filled 
in. 
Using a small superficial strip of cat 
soleus muscle and external electrodes, Eccles 
and O'Connor (1939) recorded simple spike 
potentials corresponding to a brief wave of 
negativity propagated along the muscle fibres. 
They found that with short volley intervals, 
a second nerve volley failed to set up a 
propagated impulse, due to the 'refractory 
period' of the muscle fibre, but that with 
one electrode on the localised end -plate zone 
which exists in this muscle, a smooth wave of 
negative potential was still recorded. This 
was also found with deeply curarised muscle - 
there were no propagated spike potentials, but 
a negative potential, about 10% of the height 
of the spike, was obtained at the end -plate. 
They called this non -propagated local potential 
change the 'end -plate potential' (e.p.p.) and 
concluded that a single nerve volley would also 
set up an end -plate potential in normal muscle 
(Eccles and O'Connor, 1939). 
It was found that in curarised muscle 
(Eccles, Katz and Kuffler, 1941) and in 
normal muscle (Eccles and Kuffler, 1941), when 
the end -plate potential reached a certain 
threshold level, it initiated a propagated 
action potential. It was suggested that 
this local depolarisation, the e.p.p., could 
be due to a transient effect of acetylcholine 
on the muscle membrane. The effects of 
eserine, increasing and lengthening the e.p.p., 
and curare, decreasing the e.p.p., confirmed 
the view that the e.p.p. was due to a depolarising 
action of acetylcholine, released by nerve 
impulses, on the motor end -plates (Eccles, Katz 
and Kuffler, 1942). It was also shown that 
,direct topical application of a drop of 
acetylcholine to isolated frog muscle, at the 
end -plate region only, gave rise to propagated 
action potentials, or with a subthreshold dose 
of acetylcholine, to a slow negative potential 
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only (Kuffler, 1943). The latency always 
obtained between stimulation of the motor nerve 
and the onset of the e. p. p. (about 1 msec. for 
the frog end- plate), and unchanged by curare or 
an anticholinesterase, provided a further 
argument, if one was necessary, for the inter- 
vention of a transmitter at the neuromuscular 
junction (Hunt and Kuffler, 1950). Thus in 
1950 the picture of events at the neuromuscular 
junction was as follows: nerve impulse 
transmitter (acetylcholine) - )e. muscle 
impulse contraction. 
Then it became possible to inset micro- 
electrodes directly into individual cells, and 
to record resting potentials and changes in 
il 
potential across the cell membrane (Ling and 
Gerrard, 1949; Nastuk and Hodgkin, 1950); 
and also to give doses of drugs close to the 
sensitive structures themselves, by ionophoretic 
discharge from micropipettes ( Nastuk, 1951, 1953), 
With intracellular microelectrodes in 
frog muscle fibres, small spontaneous discharges 
were detected, localised to the end -plate regions 
16. 
and not due to damage of either muscle fibre 
or motor nerve. These were similar in shape 
to the end -plate potential; but about 
of the size, and were found in normal, resting 
muscle fibres by Fatt and Katz (1952), who 
called them spontaneous miniature end -plate 
potentials (m.e.p.p.). They could also be 
recorded, their polarity being reversed, with 
external electrodes. For any one end -plate, 
the mean amplitude of m. e.p.p.'s was fairly 
constant, but their freáuency was not. They 
were found statistically to occur in a random 
manner. 
The m.e.p.p. ' s were shown by pharmacological 
tests to be caused by local random impacts of 
acetylcholine on the receptors of the muscle 
end -plate - they were reduced in size by 
curarine, and increased in amplitude and 
duration by prostigmine, as were the end -plate 
response to a nerve impulse and the depolarisa- 
tion produced by local application of acetyl- 
choline. Since chronically denervated muscle 
showed no m.e.p.p. ' s, the source of this 
acetylcholine must be the motor nerve terminals 
17. 
(Fatt and Katz, 1952). 
Fatt and Katz wondered whether each 
m.e.p.p. might be due to the impact of a single 
molecule of acetylcholine, which had leaked 
from the terminal store (Feldberg (1945) had 
concluded that the acetylcholine store in 
cholinergic tissues was in a state of flux, 
being synthesised continually to replace that 
lost by leakage), but they decided from 
experimental evidence that this was not the 
case. Instead, each me.p.p. must have been due 
to the momentary, synchronous impact of a 
packet, or 'quantum', of hundreds, or perhaps 
thousands of acetylcholine molecules (Fatt and 
Katz, 1952; Katz, 1958). Neither sodium, 
nor electrical excitability, nor the normal 
resting potential, but only the structural 
integrity of the nerve terminals, was essential 
for the release of these quanta (Katz, 1958). 
No means had been found of influencing 
the size of the quantum which was released - 
the amplitude of the m.e.p.p. was independent 
of the state of the nerve -endings and 
influenced solely by post -synaptic influences - 
while the frequency of the m.e.p.p.s was 
affected by altering the condition of the nerve - 
endings (Katz, 1958). Particularly, depolari- 
sation of the motor nerve -ending increased the 
frequency of the me. p. p. s, the frequency going 
up exponentially by a factor of 10 for a 15 mV 
lowering of the presynaptic membrane potential 
(the factor, however, depending on the ionic 
environment)(Liley, 1956, cited by Katz, 1958). 
With lowered calcium and raised magnesium 
concentrations, the amount of acetylcholine 
released by a nerve impulse was reduced, and 
therefore the e.p.p. was reduced in size - and 
it was possible to show that the fluctuations 
of the e.p.p. were of a discontinuous step -wise 
nature, involving quantal steps, each step 
corresponding to a unit identical with a 
spontaneous m.e.p.p. (Katz, 1958). 
Therefore, Katz and his colleagues reached 
the following conclusions: that the m. e. p. p. 
represented the least quantum of action in 
neuromuscular transmission, that this unit 
of acetylcholine release remained unchanged 
whether it occurred spontaneously or during 
motor nerve activity, and that the impulse, 
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by depolarising the membrane of the motor nerve 
terminal, momentarily increased the statistical 
chances of quantal release by a factor of 
several hundred thousand, resulting in the output 
of sufficient quanta of acetylcholine to 
produce a supra -threshold e.p.p. and hence an 
action potential. 
Acetylcholine was known to be synthesised 
in the motor nerve (Feldberg, 1943) and to be 
present in the nerve not in free solution but 
in some bound form (Feldberg, 1945). Electron 
microscope studies showed that motor nerve 
terminals contained, as well as mitochondria, 
numerous small vesicular bodies - synaptic 
vesicles (Robertson, 1956). Robertson 
suggested that these might be analogous to 
secretion granules, and might contain acetyl- 
choline. The presence of acetylcholine in 
packets' like this would conform very well 
with the idea of quantal release. 
This means that for acetylcholine to be 
released from the nerve terminals, it must 
penetrate two barriers, the 'vesicle' capsule 
and the cell membrane. On the mode of this 
release there can at present only be speculation. 
Katz however has suggested that there are 
frequent thermal collisions between vesicles 
and cell membrane, but that only when 'key 
molecules' on vesicle and cell membrane meet 
does a local membrane breakdown follow which 
allows acetylcholine to escape into the 
synaptic cleft. In the resting state, the 
probability of such an event is low, but the 
nerve impulse or applied depolarisation 
increases the reactivity (i.e. number of 'key 
molecules') of the nerve membrane, and so 
increases the probability of successful collisions, 
and thus results in the synchronous release of 
many quanta (Katz, 1958, 1962). 
Once the transmitter has been released 
from the nerve -endings, the next stage is 
probably a simple process of diffusion. By 
using a micropipette and the technique of iono- 
phoresi s, a dose as small as 10-16 gm.mol. of 
acetylcholine was found to give rise to a 
muscle impulse, if it was given close enough 
to the end -plate (Katz, 1958). When the 
diffusion path was reduced to the order of 
microns an artificial e.p.p. could be obtained, 
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whose rise and fall was not much slower than 
that of one naturally produced by the transmitter 
(Krnjevic and Miledi, 1958, cited by Katz, 1962). 
It was shown that the receptors for 
acetylcholine must be on the external surface 
of the post- synaptic membrane, since with the 
ionophoretic micropipette, if acetylcholine 
was released outside the cell, an impulse was 
produced, while the same dose, injected into 
the interior of the cell, produced no effect 
(Katz, 1958). But the nature of these receptors 
is still unknown. 
However, when acetylcholine reacted with 
these 'receptors', a depolarisation of the 
membrane did take place and it was found that 
this was accompanied, and presumably caused, 
by a considerable lowering of the membrane 
resistance of the end -plate (Katz, 1958). 
This lowered resistance and depolarisation was 
not due simply to the rapid transfer of acetyl- 
choline ions across the membrane, since the 
electrical charge transfer which occurred during 
the local depolarisation was much greater than 
the total charge carried by the quantity of 
acetylcholine released by an impulse (Castillo and 
22. 
and Katz, 1956) and also, intracellular applica- 
tion of acetylcholine was ineffective, as mention- 
ed before (Katz, 1958). 
The acetylcholine- receptor reaction must 
therefore cause an increase in the ionic 
permeability of the membrane. From determina- 
tions of the mull- point , the level of the 
membrane potential at which the e.p.p. reverses 
its sign, it seems that there is an unselective 
increase in permeability to all ions, or 
perhaps a combination of high sodium and high 
potassium permeability (Katz, 1958). The 
action potential, on the other hand, is due to 
selective, out -of- phase permeability changes, 
first to sodium, then to potassium (Hodgkin, 
1951). Later results seem to show a simultaneouE 
rise of sodium and potassium permeability, and 
little participation by chloride and other anions 
(Katz, 1962). Sodium itself is not essential, 
and can be replaced by other cations (Katz, 1958). 
The present picture of events at the neuro- 
muscular junction then seems to be as follows. 
Acetylcholine, synthesised in the motor nerve 
cell, is stored in vesicles at the nerve 
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terminal, and in the resting state, these 
vesicles are discharged in a random fashion, 
releasing quanta of acetylcholine which produce 
small local depolarisations of the motor end- 
plate - miniature end -plate potentials. The 
nerve impulse, by depolarising the membrane, 
momentarily increases the statistical chances 
of quantal release, and this released acetyl- 
choline reacts with 'receptors' on the external 
surface of the end -plate membrane and causes 
an increased ionic permeability of the membrane, 
and hence a local depolarisation - the end -plate 
potential. When this end -plate potential 
reaches a threshold value, it initiates a 
propagated action potential, and muscle 
contraction follows. The acetylcholine is 
destroyed by cholinesterase which is present 
in high concentrations on the membrane of the 
muscle end -plate. 
(b) THE AUTONOMIC GANGLION 
The story for the ganglion is similar 
to that for the neuromuscular junction. As 
described in the first section, it had been 
2L-. 
shown that acetylcholine was released from the 
preganglionic nerve -endings on stimulation, and 
that it could stimulate ganglia. Paton and 
Perry (1953) showed, using external electrodes, 
that close arterial injection of small doses 
(1 - 10 µg) of acetylcholine caused a transient 
depolarisation of the superior cervical ganglion 
cells in the cat, and that this depolarisation 
was prolonged by eserine. Similar results 
were obtained for the parasympathetic ciliary 
ganglion (Perry and Talesnik, 1953). 
There had been difficulties involved in 
the acceptance of the idea of cholinergic 
transmission in ganglia, mainly due to the 
interpretation of the complex action potential 
of the ganglion obtained with extracellular 
electrodes. However, when intracellular 
electrodes were used to record the action 
potential in response to preganglionic stimula- 
tion, in the isolated superior sympathetic 
ganglion of the rabbit, it was clearly shown 
that a small depolarisation, the synaptic 
potential, preceded the spike potential, and in 
fact generated the spike when it depolarised 
25. 
the membrane to a critical level (Eccles, 1955). 
Nishi and Koketsu (1960) used intracellular 
electrodes to record spike potentials in 
response to antidromic, direct and orthodromic 
stimulation in ganglion cells of the isolated 
frog sympathetic chain. The orthodromic responsé 
showed an initial depolarisation phase (the 'syn -: 
aptic potential'),and a small dip after the 
spike crest, which was slightly lower than that 
of the antidromic response. Also by displacing 
the resting membrane potential, they found the 
reversal point of the synaptic potential to be 
about -15 mV. They suggested therefore that 
the action of the transmitter at the frog 
sympathetic ganglion was similar to that of 
acetylcholine at the neuromuscular junction, 
and that it caused the permeability of the 
synaptic membrane to increase briefly to certain 
ions, and hence to short- circuit the active 
neuronal membrane (Nishi and Koketsu, 1960). 
Using a similar preparation and 
technique, Blackman, Ginsborg and Ray (1963) 
confirmed Nishi and Koketsuts findings, and 
by timing an orthodromic stimulus to arrive at 
 .2.6, , 
different points on an antidromic response and 
recording the changes in shape of the spike, 
they showed that it was likely that the trans- 
mitter was responsible for the synaptic potential 
and that its action modified the shape of the 
spike action potential. The mode of action 
of the transmitter was similar to that at 
the neuromuscular junction, but its duration of 
action was longer, Presumably due to the known 
absence of cholinesterase in frog sympathetic 
ganglion cells (Blackman, Ginsborg and Ray, 
1963a). 
The ganglion blocking drugs mecamylamine 
and hexamethonium were added to the bath fluid, 
and they reduced the rate of rise of the 
'synaptic step' and increased the 'positive 
of 
phase'Çafter hyprpolari sation. Acetylcholine 
was applied by ionophoresis through a micro- 
pipette and found to depolarise the ganglion 
cell. These facts were consistent with 
acetylcholine being the transmitter - the action 
of the blocking drugs was what would be 
expected from substances which reduced the 
intensity of action of the transmitter (Blackman, 
Ginsborg and Ray, 1963a). 
27. 
The existence of miniature synaptic 
potentials in frog ganglion cells, mentioned 
by Nishi and Koketsu (1960), was confirmed 
by Blackman, Ginsborg and Ray (1963b) - small 
subthreshold depolarisations, occurring 
spontaneously, were recorded from about 3 of 
the cells tested. Since they persisted in 
concentrations of K+ which blocked presynaptic 
conduction, their release must be spontaneous. 
They were reduced in amplitude by tubocurarine, 
and would seem to be analogous to the miniature 
end -plate potentials at the neuromuscular 
junction, due to the action of 'packets' of 
acetylcholine. They occurred at a random 
freuency, usually less than 1/3 sec., and 
their frequency was increased by increasing the 
tonicity of the bath fluid, or by increasing the 
concentration of K+ above that needed to block 
presynaptic transmission (probably due to 
depolarisation of the presyna -otic terminals). 
Since De Robertis and Bennet, and Taxi, 
have described 'synaptic vesicles' in presynaptic 
terminals of the frog sympathetic ganglion (see 
Blackman, Ginsborg and Ray, 1963b), it seems 
likely that acetylcholine may be released here 
ln. 
in a quantal fashion as at the neuromuscular 
junction. No miniature synaptic potentials 
have as yet been observed in mammalian ganglion 
cells (Eccles, 1955), but they have been shown 
to release acetylcholine spontaneously when 
perfused with high K+ solutions (Brown and 
Feldberg, 1936). 
Responses to orthodromic stimuli were 
recorded when transmission was depressed by a 
high Mg++: Ca ++ ratio in the bath fluid 
(Blackman, Ginsborg and Ray, 1965c). The 
amplitude of successive synaptic potentials 
varied, and mathematical analysis of the 
variation showed that it was consistent with 
the idea that the transmitter was released in 
the form of quanta identical with those which 
produced miniature synaptic potentials, and 
that the depression of transmission was caused 
by a reduction in the number of quanta released 
by a stimulus. As expected, the responses 
fluctuated much less when transmission was 
depressed with tubocurarine, since its action 
is believed to be post -synaptic, and it would 
not affect the number of quanta released. 
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Though the evidence is not yet Quite 
strong enough for a definite conclusion to be 
reached, it seems likely that transmission at 
the sympathetic ganglion, at least in the frog, 
is very similar to that at the neuromuscular 
junction i.e. by the _uantal release of acetyl- 
choline, the nervous impulse being transmitted 
by a large increase in the number of quanta 
released simultaneously, due to its wave of 
depolarisation. Enzymic destruction of 
acetylcholine seems however to be less important 
at the ganglion, vihere the pattern of cholin- 
esterase distribution is di _fferent from that 
at the neuromuscular junction. 
30. 
III.MECHANISMS OF BLOCK 
OF CHOLINERGIC PERIPHERAL SYNAPSES 
Following from the preceding description 
of cholinergie transmission it can be seen 
that drugs can interfere with transmission at 
the neuromuscular junction or the ganglionic 
synapse in the following ways: (1) by prevent- 
ing or diminishing the release of acetylcholine 
from the pre- synaptic nerve- endings, (2) by 
competing with acetylcholine for the receptors 
on the post -synaptic membrane and thus preventing 
it from exerting its depolarising action, (3) by 
altering the condition of these receptors so 
that they are no longer sensitive to the 
depolarising action of acetylcholine, or (4) 
by inhibiting cholinesterase and thus preventing 
the destruction of acetylcholine. 
Although transmission is all -or -none at 
each individual junction of one nerve -fibre and 
one muscle fibre, and an antagonist will either 
block or fail to block any one end- plate, a 
graded response i.e. a partial paralysis can 
be obtained if only a certain proportion of the 
end -plate population is blocked. Except in 
experiments using electrical micro- methods, 
the graded response is the tyre which is 
measured. 
Groups of drugs are known which interfere 
with transmission in each of the four ways 
mentioned above. For reasons of space and 
time, and because they are less relevant to 
the experimental investigation to be described, 
groups (1) and(4) will only be mentioned briefly. 
The best -known example of group (l) is botulinus 
toxin; acetylcholine release can also be 
prevented experimentally by local anaesthetics, 
hemicholinium compounds, and e_..cess of magnesium 
or deficiency of calcium ions. Group(4), the 
anticholinesterases, comprises a large number 
of compounds of two main types, reversible 
eg. eserine, and irreversible, those which form 
a covalent bond with the receptor eg. DFP. The 
effect of applying an anticholinesterase may be 
either to facilitate a submaximal stimulus, or 
to cause block resulting from the prolonged 
action of excess acetylcholine, depending on 
dosage, stimulation etc. 
Groups(2) and(3) will now be considered 
in more detail. 
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(a) The Neuromuscular Junction 
In the latter half of the last century, 
Claude Bernard studied the properties of the 
paralytic South American poison, curare. 
He injected the drug into a frog in which the 
vessels of one leg were ligatured, and found 
that only the ligatured leg responded to 
stimulation of the nerve, but that the other 
paralysed leg still responded when the muscle 
was stimulated directly. Thus neither the 
muscle itself nor transmission of impulses 
along the nerve was affected. He concluded 
that curare must act at the junction between 
nerve and muscle and until about 1935 it was 
assumed,without experimental proof, that curare 
acted by 'inhibiting' the motor end- plate, since 
it lay between nerve and muscle. 
Then Dale, Feldberg and Vogt (1936) 
showed that acetylcholine was released on 
stimulation of the motor nerves to voluntary 
muscle, and suggested that it acted as a trans- 
mitter, stimulating the motor end -plate. They 
also showed that curare did not prevent the 
release of acetylcholine, and suggested that 
it 'rendered the receptive element resistant to 
the action of acetylcholine'. Curare was 
found to inhibit the twitch response of a 
voluntary muscle to injected acetylcholine even 
more than that to nerve stimulation (Brown, 
Dale and Feldberg, 1936). 
Using external electrical recording 
techniques, curare was shown to prevent the 
production of a propagated action potential in 
the muscle by nerve stimulation (Eccles and 
O'Connor, 1939), and to diminish the size of 
the end-plate -potential, which was believed to 
be due to the depolarising action of the trans- 
mitter (Eccles, Katz and Kuffler, 1941). It 
was known that curare was an amorphous mixture 
of quaternary alkaloids, and it had been 
recently found that ( +)- tubocurarine chloride, 
crystallised from crude curare, was a bis- 
quaternary benzyl isocyuinolin_e (King, 1935). 
Since acetylcholine was also a cuaternary 
ammonium compound, and since it was believed to 
produce its depolarising action at the motor 
end -plate by combining with specific receptors 
on the surface, it was suggested that curare 
blocked the action of acetylcholine by combining 
with these same receptors (Eccles, Katz and 
Kuffler, 1942). Kuffler (1943) demonstrated 
antagonism between acetylcholine and curarine 
applied directly to frog end -plates. Curare 
could also be antagonised by partial depolarisa- 
tion of the membrane, by drugs or an applied 
current, which would sum with the reduced e.p.p. 
from nerve stimulation, and by anticholinesterasds, 
which presumably increased the amount of acetyl- 
choline available to compete with curare for 
receptors (Hunt and Kuffler, 1950). 
It had been known for a long time that 
Luaternary ammonium compounds could cause 
neuromuscular block (see Ing, 1936), and after 
the demonstration that tubocurarine was a 
bis- quaternary compound, some simple polymethyl- 
ene bis- ammonium salts were prepared and tested 
for activity at the neuromuscular junction. 
The most active blocking agent among these was 
decamethonium (Barlow and Ing, 1948; Paton and 
Zaimis, 1948). 
It was soon shown, however, that the 
blocking actions of tubocurarine and decamethonium 
were not identical. In different species and 
even in different muscles in the same animal 
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there seemed to be an inverse relationship 
between senivity to decamethonium and 
sensitivity to ( +)- tubocurarine. Decamethorium 
possessed stimulant activity lacking in 
( +)- tubocurarine. On the cat tibialis prepara- 
tion, decamethonium potentiated the twitch 
before blocking it, and fasciculations of the 
muscle could be seen between. contractions. 
It caused a contracture of the frog rect:_is, of 
avian muscle and of denervated mammalian muscle. 
Block by decamethonium was not relieved by 
anticholinesterases, or any of the other agents 
which could diminish block by ( +)- tubocurarine. 
A muscle blocked by decamethonium could sustain 
a tetanus, unlike a muscle blocked by ( +) -tubo- 
curarme. Overall, decamethonium seemed to 
show more similarities to acetylcholine than to 
( +)- tubocurarine (Paton and Zaimis, 1949; 
Paton, 1951). 
Burns and Paton ( 1951) then showed that 
decamethonium caused a depolarisation of the 
end -plate region of the cat's gracilis muscle, 
and suggested that this depolarisation, which 
persisted for the same length of time as the 
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block, was the cause of the block. They 
observed that during the action of decamethonium 
the end -plate region was inexcitable to direct 
stimulation, that the propagation of a directly 
excited action potential along the muscle fibre 
was blocked at the end -plate region, that the 
propagation threshold at the end -plate was 
raised, and that artificial repolarisation of 
the end -plate reversed the block. These 
features of decamethonium block were not shared 
by tubocurarine, but they could be reproduced 
by acetylcholine in the presence of eserine, or 
by application of a cathode at the end -plate 
region. Decamethonium block could, in fact, 
be antagonised by tubocurarine, as would be 
expected if it acted similarly to acetylcholine, 
while by the same token it was not antagonised 
but rather intensified by anticholinesterases. 
They concluded that decamethonium blocked the 
neuromuscular junction by persistent depolarisa- 
tion of the end -plate region, this electrical 
inexcitability preventing e.p.p. s from exciting 
the adjacent muscle membrane, whereas tubo- 
curarine blocked by increasing the threshold of 
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the end -plate to acetylcholine (Burns and Paton, 
1951; Paton and Zaimis, 1952). 
Neuromuscular blocking drugs subseryuently 
tended to be divided into two classes, 
competitive or curare -like, and depolarising 
or decamethonium -like. In support of this it 
was noted that sensitivity to decamethonium 
varied from species to species and from muscle 
to muscle. There seemed to be a reciprocal 
relationship between the sensitivities to the 
two types of blocking drugs for any given 
muscle e.g. decamethonium was more effective 
in blocking 'red' muscle than 'white' muscle 
in the cat, while for tubocurarine the opposite 
was the case (Paton and Zaimis, 1952; Zaimis, 
1953). 
However, it soon appeared that the action 
of decamethonium could not be regarded as 
purely depolarising in all situations. 
Jenden, Kamijo and Taylor (1951) found that 
decamethonium had a 'biphasic' blocking action 
on the isolated rabbit lumbrical muscle. 
The first phase showed the usual properties of 
decamethonium block in vivo, but the second 
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phase, slower in onset, could be reversed by 
eserine. Zaimis (1953) tested decamethonium 
on eight different species and found that on 
some of them (e.g. monkey, rabbit, dog) the 
block had some characteristics of depolarisation, 
some of competition and some absent from 
either type. Successive doses of decamethonium 
had less and less effect (Burns and Paton (1951) 
had even found this for depolarisation on the 
cat E racilis muscle) and the block was antagon- 
ised by a tetanus and neostigmine, and potentiated 
by curare. Zaimis therefore maintained that 
decamethonium possessed a dual mode of action 
in some species and that this explained the 
varying sensitivity of different species to 
decamethonium (Zaimis, 1953). 
Thesleff (1955a) used both external and 
intracellular recording on the isolated frog 
sartorius preparation and found that acetyl- 
choline, decamethonium, suxamethonium and 
nicotine all acted in a óualitatively similar 
way. They caused a brief depolarisation of 
the end -plate region, which subsided spontaneously 
without removal of the drugs, the membrane 
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potential returning to about its normal value. 
Neuromuscular block developed during the 
depolarisation phase, persisted despite repolari 
sation of the membrane, and only reached its 
maximum when the membrane potential had returned 
to its normal value. During the period of 
neurAmuscular block, the end -plate region was 
insensitive to the depolarising effect of a 
further dose of acetylcholine or any of the 
other drugs. Thesleff concluded that at least 
for the frog, neuromuscular block caused by 
these four 'depolarising' drugs was not due to 
persistent depolarisation of the end -plate 
region or adjacent muscle membrane, but to a 
decrease in sensitivity of the end -plate to the 
transmitter (Thesleff, 1955a). 
Thesleff (1955b) repeated these experiments 
on the rat phrenic nerve -diaphragm preparation, 
and found that acetylcholine, decamethonium and 
suxamethonium initially depolarised the end -plate; 
i 
region, though to a lesser extent than on the 
frog, and also the whole muscle membrane showed 
some degree of depolarisation. During complete 
neuromuscular block, there was a tendency to 
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repolarisation, though not to the resting level. 
However the depolarisation of the membrane 
obtained by altering the potassium concentration 
in the bathing fluid, which was required to 
produce neuromuscular block, was greater than 
that obtaining during block due to these drugs. 
Also, during block by the drugs acetylcholine 
no longer depolarised the muscle membrane and 
so Thesleff concluded that their action on the 
rat was perhaps initially by blocking a few 
fibres by depolarisation_, but mainly by 
decreasing end -plate sensitivity to the trans- 
mitter (Thesleff, 1955b). 
Using internal recording microelectrodes 
and ionophoretic application of drugs from 
micropipettes on the frog sartorius preparations 
Castillo and Katz (1957a) confirmed that ( +)- 
tubocurarine did not alter the resting potential 
of the muscle membrane, and that it reduced 
the transient depolarisation caused by pulses 
of acetylcholine, or steady depolarisation 
caused by continuous release of acetylcholine. 
This effect was obtained only with external 
application of ( +)- tubocurarine, but not when 
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it was applied inside the muscle fibre. These 
results support the idea of competition between 
( +)- tubocurarine and acetylcholine for receptors, 
but do not prove it to be true, since the 
traditional test of increasing doses of the 
'competing' drugs cannot be used with this 
local method of application. The time of 
decay of ( +)- tubocurarine`s inhibiting action 
was found to be greater than that of the 
depolarising action of acetylcholine or 
carbachol (carbaminoyl choline), a stable 
choline ester. This slow decay was not likely 
to be limited by diffusion, but was suggested 
to be due to slow dissociation of the drug - 
receptor complex (Castillo and Katz, 1957a). 
It had been previously found (e.g. van 
Maanen, 1950) that the antagonism between 
acetylcholine and ( +)- tubocurarine was competitive 
when tested quantitatively using contracture 
of the frog rectus as a measure of drug action. 
Jenkinson (1960) used the depolarisation of 
the end -plate region of frog skeletal muscle 
(recorded with extracellular electrodes) or 
of individual end -plates (recorded with intra- 
cellular/ 
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cellular microelectrodes) by acetylcholine in 
the absence or presence of ( +)- tubocurarine. 
He showed that the equation 
CA] - 1 = K [...6 where LAI = agonist 
CAJ concentration in 
presence of 
antagonist 




[i] = antagonist 
concentration 
K = affinity 
constant of 
antagonist 
(held over a wide range of concentrations. This 
equation expressed the relation between agonist 
and antagonist where both compete on a one-to-one 
¡basis for the same receptors (Gaddum, 1943). 
I Jenkinson_ therefore said that his results were 
consistent with the hypothesis that ( +) -tubo- 
curarine is a competitive antagonist of acetyl- 
choline at the neuromuscular junction. 
Castillo and Katz (1957b) have also 
used this method of ionophoretic application to 
compare the time course of action of acetylcholine 
and of some stable depolarising agents. The 
time course of an acetylcholine potential was 
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faster than that of the other drugs - by a 
factor of about 2 for carbachol, 2 to 3 for 
nicotine and succinyl choline, and about 10 for 
decamethonium. In the presence of prostigmine, 
the difference between acetylcholine and 
carbachol became insignificant, which suggests 
that for these two, and probably also for 
nicotine and succinyl choline, the time course 
differences depend rather on the kinetics of 
local diffusion and hydrolysis than of drug - 
receptor reactions. 
Castillo and Katz (1957c) further showed 
that decamethonium and also choline had three 
effects (i) weak depolarisation (ii) potentiation 
of acetylcholine in normal Ringer solution (iii) 
inhibition of acetylcholine in the presence of 
prostigmine. Also only inhibition occurs when 
decamethonium is given with carbachol instead 
of with acetylcholine. They suggested therefore 
that (ii) was due to inhibition of acetylcholine - 
esterase by the drug. To explain the inhibition 
(iii), they postulated first a drug- receptor 
reaction similar to that of an enzyme reaction 
(Michaelis theory):- 
S + R SR1SR' where S = drug 
R = receptor 






( +)- tuoocurarine, they suggested, proceeded 
only to the first step, the inactive compound, 
whereas for decamethonium and other 'depolarising 
drugs, the rate constant for the second reaction, 
from the inactive to the active form was very 
slow. Thus, though it could depolarise, it 
antagonised the depolarisation produced by 
fast and powerful agents such as acetylcholine 
and carbachol. 
This scheme, however, did not explain the 
'desensitisation' which Thesleff (1955a and b) 
had shown to be the cause of neuromuscular 
block by acetylcholine or depolarising drugs. 
Castillo and Katz therefore added a third step 
to the above equation: - 
(1) Ach + R---1 Ach R ' Ach. R'- )Ach + R' 
where Ach = acetylcholine 




Recovery of the receptor from R' to R was 
postulated to be very slow. Thus a high 
concentration of acetylcholine would result 
in most of the receptors being converted into 
the refractory form R' (Castillo and Katz, 1957c). 
Katz and Thesleff (1957a) also considered 
two other hypotheses to explain the relation- 
ship between depolarisation and desensitisation: 
that the two reactions, a depolarising reaction 
which reached equilibrium rapidly, and a 
desensitising reaction which proceeded slowly 
occurred either (2) consecutively or (3) in 
parallel:- 
(2) S + A ̀  SA x SB where S = drug 
fast slow 





A = free 
receptors 









These hypotheses led to the predictions 
that the onset of desensitisation should be 
faster than the recovery, and that complete 
desensitisation should only occur when the rate 
of onset was very much faster than that of the 
recovery. However, by applying steady 'condi- 
tioning' and pulsatile 'test' doses of acetyl- 
choline to receptive spots on frog end -plates, 
Katz and Thesleff showed that these predictions 
on desensitisation were not fulfilled. Half - 
desensitisation was found to develop at a rate 
equal to, or lower than, that of the subsequent 
recovery, instead of as predicted, at a rate 
of development twice that of recovery. These 
schemes therefore could not be accepted - what 
was apparently needed was a reaction in which 
the recovery process B to A, was slowed by 
the presence of the drug. 
They then put forward a further hypothesis 





S + A Mast 
S¡AI 
k4 k3 II ki (slow) 
S + B 
fast 
` SB ` b 
where a and b are affinity constants and ki, 







This scheme could not be rigorously tested, 
since with the ionophoretic method the values 
of S are not known, but it would be fitted 
b ki 
if ki ,k3, b j;-,.a. and . 
a 
k2 
According to this hypothesis, the free 
receptors are distributed, even in the absence 
of the drug, between states A and B i.e. some 
of the receptors are present in the refractory 
form, and due to their high affinity (a 1) 
will preferentially absorb small quantities of 
applied acetylcholine. 
Katz and Thesleff found that a small 
steady dose of carbachol could facilitate the 
action of an added pulse of the drug, and they 
explained this on the basis of the above 
hypothesis (4). The effect of the initial 
small dose would be mainly to occupy the B -type 
receptors, which have a high affinity but no 
depolarising power. When the second dose was 
added, a smaller fraction of the drug molecules 
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would be absorbed by B receptors and a larger 
fraction would be available to cause depolari- 
sation by combining with A- receptors, than when 
this dose was given alone. This is of course 
different from the facilitation of acetyl- 
choline action by cholinesterase inhibitors. 
As stated at the beginning of this 
section, drugs can also interfere with 
cholinergic transmission by inhibiting cholin- 
esterase and so preventing the destruction of 
acetylcholine. This can cause either a 
potentiation of the stimulant action of acetyl- 
choline, or a blocking action due to the 
prolonged effect of excess acetylcholine. It 
is not proposed to discuss anticholinesterase 
activity here, but it must be mentioned that 
some drugs classified as cholinesterase 
inhibitors also possess, particularly in high 
concentrations, some blocking action on the 
motor end -plate, and similarly many neuro- 
muscular blocking agents also have anti- 
cholinesterase activity. This anticholinester- 
ase activity may mask blocking activity or 
simulate stimulant activity on test preparations, 
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and it is therefore important to discover from 
in vitro experiments the anticholinesterase 
activity of compounds thought to be active at 
the neuromuscular junction. This possible 
inhibitory activity on the enzyme also reduces 
the value of attempts to classify compounds 
as 'competitive' or 'de_olarising' by finding 
whether they are reversed by a known anti= 
cholinesterase. For example, Thesleff and Unna 
(1954) investigated the Dolymethylene bis- 
trimethyl ammonium series, and in their results 
reversal of paralysis by the anticholinesterase 
Tensilon (Katz and Thesleff, 195m) does not 
! seem to correlate with ability to cause 
contracture of the chick gastrocnemius. 
If the drug being tested is a more potent 
inhibitor than the 'standard' anticholinesterase, 
then obviously it will not be reversed by it 
The drug Mytolon (Win 2747) was originally 
classed as a 'depolarising' blocking agent, 
since it was not reversed by Tensilon, but it 
was then found to be a more powerful inhibitor 
f cholinesterase than Tensilon (Tabachnick 
et al., 1958). The compound Win 8078 reverses 
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both the block caused by ( +)- tubocurarine 
and that caused by decamethoninm - this may 
be due to its anticholinesterase activity and 
its 'curare -like' activity respectively 
(Blaber, 1960). 
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(b) The Autonomic Ganglion 
In the latter half of the nineteenth 
century it was shown that the alkaloid nicotine 
could first cause slowing of the dog's heart, 
and then prevent vagal stimulation from 
producing slowing of the heart. The site of 
this stimulation and then block by nicotine 
was some connecting link between the vagas 
trunk and the site of action of atropine, which 
prevented the initial slowing by nicotine. 
In 1889 Langley and Dickinson showed that 
the site of action of nicotine was the 
autonomic ganglion. Topical application of 
nicotine to the superior cervical ganglion 
of the cat caused first stimulation - pupillary 
dilatation, as with electrical stimulation of 
the cervical sympathetic chain - and then 
block at the ganglion - preganglionic electrical 
stimulation was ineffective, while post - 
ganglionic stimulation was still effective. 
Later, Langley (1901) showed that nicotine 
still stimulated the sympathetic ganglion after 
the preganglionic nerve had been cut and 
allowed to degenerate, and hence deduced that 
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the site of action of nicotine was the ganglion 
cell surface and not the preganglionic nerve 
ending. 
The simplest quaternary ammonium compounds 
iere also shown to be active at the autonomic 
ganglion. Tetramethylammonium was shown to 
have an action similar to that of nicotine 
i.e. stimulation followed by block, demonstrated 
on the blood pressure of the cat; whereas 
tetraethylammonium possessed only the blocking 
action, without the preliminary stimulation 
(Burn and Dale, 1915). Thus already two types 
of agent blocking at the ganglion had been 
shown to exist, as was subsequently found to be 
the case at the neuromuscular junction, but no 
attempt at analysis of their modes of action was 
made until much later. By this time, other 
ganglion blocking agents had been synthesised, 
in particular the polymet hylene bis- ammonium 
salt hexarnethonium (Paton and Zaimis, 1949). 
Paton and Perry (1953) studied the 
effects of acetylcholine and several ganglion 
blocking drugs on the cat superior cervical 
ganglion using electrical recording of the 
action potential from the ganglion with 
53. 
external electrodes. Small doses of acetyl- 
choline produced only a transient depolarisation 
of the ganglion, while large doses of acetyl- 
choline, or doses of nicotine or tetramethyl- 
ammonium, resulted in a considerable depolarisa- 
tion accompanied by a reduction in the height 
of the action potential. All other ganglion 
blockers tested i.e. hexamethonium, penta- 
methonium, tetraethylammonium, tubocurarine and 
decamethonium (in large doses), decreased or 
abolished the spike without any trace of 
depolarisation. Thus ganglion-blockers could 
be divided into two groups, depolarising block- 
ing drugs and competitive blocking drugs, this 
classification corresponding to the previous 
one of whether or not they produced initial 
stimulation of the ganglion. This classifica- 
tion was analogous to that out forward for the 
neuromuscular junction, but Paton and Perry 
noted that at the ganglion, decamethonium 
appeared to act as a competitive blocker, 
whereas at the neuromuscular junction it was 
considered a depolarising blocker (Burns and 
Paton, 1951). 
J 
However, the action of nicotine was not 
identical with that of acetylcholine or tetra - 
methylarnrnonium. With tetramethylammonium, 
recovery from depolarisation and recovery 
of spike height were almost parallel, but with 
nicotine the depolarisation was much more 
transient, and the reduction in spike height 
lasted much longer than the depolarisation e.g. 
in one experiment, ganglion negativity had 
disappeared 3 min. after the injection, while 
the spike height did not return to normal for 
30 min. This suggested to Paton and Perry that 
nicotine might have a mixed action, initially 
depolarising and subsequently competitive. To 
test this, they gave a second identical dose 
of nicotine shortly after the ganglion depolari- 
sation had disappeared, and found as they 
expected, that it produced much less depolari- 
sation than the original dose. However, this 
might eoually well be explained, in the light 
of further findings at the neuromuscular 
junction, as a desensitisation following the 
initial depolarisation. 
Acetylcholine appeared to occupy a 
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position between that of tetramethylammonium 
and nicotine, in that the rate of recovery of 
spike height was slower than the rate of 
repolarisation. This could also mean that 
ganglion block by acetylcholine is at least 
partly due to receptor desensitisation, as has 
been shown to be the case at the neuromuscular 
junction (Thesleff, 1955). If ganglion 
block by nicotine and acetylcholine were due 
to desensitisation, that would leave tetra - 
methylammonium in a lonely position - is its 
blocking action due only to the depolarisation 
it produces or is there a concurrent desensitisa- 
tion? Unfortunately no work similar to that 
of Katz and his colleagues on neuromuscular 
blocking agents has so far been performed on 
the ganglion, to verify or refute the 
existence of desensitisation block at this 
site. 
Ganglion blocking drugs have been 
administered to the frog sympathetic ganglion, 
while intracellular recording was in progress 
(Ray, 1962; Blackman, Ginsborg and Ray, 1963). 
The non -depolarising drugs hexamethonium, 
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mecamylamine and ( +)- tubocurarine decreased 
and then abolished the orthodromic spike 
leaving only the synaptic potential,while not 
affecting the antidromic spike or the membrane 
potential. This is as would be expected on 
the assumption that they reduced the intensity 
of transmitter action, and it was therefore 
tentatively assumed that they acted post- 
synaptically by combining with specific receptors 
for acetylcholine (Ray, 1962). 
Nicotine, on the other hand, first 
depolarised the cell and abolished the ortho- 
dromic spike, uncovering the synaptic potential, 
but the depolarisation passed off while the 
orthodromic spike remained blocked. When low 
divided doses of tetramethylammonium were given, 
block could be obtained without depolarisation. 
Ray concluded that 'depolarising' ganglion 
blockers do not necessarily block by depolari- 
sation, since block occurs after peak depolari- 
sation has occurred, transmission is not 
restored after membrane potential is restored 
and the antidromic response is not blocked at 
any stage (it can be decreased by depolarisation 
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e.g. by increasing the Ca 
++ 
concentration), 
He did not speculate on other possible modes 
of blocking action, but it seems likely that 
events at the ganglion are similar to those 
at the neuromuscular junction; and that 
hypotheses put forward for neuromuscular block- 
ing action may be extended to cover the ganglion. 
Investigations on the ganglion have mainly been 
hampered by technical difficulties, but it is 
hoped that in the near future some further 
work may emerge which will shed more light on 
events there. 
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IV. THE PROPERTIES OF ONIUM SALTS 
A. THE NEUROMUSCULAR JUNCTION 
(a) Complex Onium Salts 
In the middle of the 19th century, Crum 
Brown and Fraser converted a number of alkaloids, 
all of which had pronounced effects on the 
central nervous system, from tertiary bases to 
quaternary metho salts. They found that these 
quaternary salts had lost almost entirely the 
typical central actions of their parent bases, 
and had acquired a new property, the production 
of a curare -like paralysis of voluntary muscle. 
By performing experiments similar to those of 
Claude Bernard on the frog, they showed that 
the paralysis was like that of curare nervous 
conduction and direct excitability of the 
muscle were unaffected, and so the drug action 
must be at the neuromuscular junction. They 
found that the methiodides and methosulphates 
of strychnine, brucine, thebaine, codeine, 
morphine, atropine and N- methylconiine all 
showed this property, though nicotine was 
anomalous. They also found that this action 
was not confined to the metho salts of complex 
alkaloids - it was also by their eth 
salts and even by the simplest quaternary 
salt, tetramethylammoníum chloride. They 
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considered that the production of curare -like 
paralysis was a property of quaternary ammonium 
salts as a class (Crum Brown and Fraser, 1869 
and 1872; see Ing, 1936). 
Ing (1936) used the term 'onium salts' for 
cations of the ammonium, sulphonium, phosphonium 
type in which the central atom satisfies its 
maximum covalency and also exerts one 
electrovalency, and he reviewed the literature 
concerning the curare -like properties of these 
salts. Phosphonium salts (Vulpian, 1868; 
Lindemann, 1898), sulphonium salts (Crum Brown_ 
and Fraser, 1872), arsonium and stibonium salts 
(Rabateau, 1882) and iodonium salts (Gottlieb, 
1894) had all been shown to have this activity. 
Curarine, an active alkaloid from curare isolated 
by Boehm (1897), was itself shown to be a 
quaternary base. 
Though there was a large number of compounds 
known to possess this neuromuscular blocking 
activity, attempts to compare their activity 
quantitatively had not been a success due to 
poor testing techniques. Ing and Wright 
(1932, 194) used the isolated frog sartorius 
preparation, a thin muscle where diffusion 
factors should be negligible, times of 
paralysis short, and recovery quick. They 
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measured the times of paralysis for e quimolar 
concentrations, and found that curare -like 
activity was remarkably independent of detailed 
chemical structure i.e. the nature of the 
central atom and the radicals attached to it. 
This suggested that the activity of onium 
compounds depended rather on their ionic 
character. However, in the simplest compound, 
tetramethylammonium, successive replacements of 
methyl groups by ethyl considerably decreased the 
activity. Taking into account variations in 
some other simple quaternary salts, it seemed 
that there might be a certain ionic radius at 
which there was minimum activity (Ing and 
';1 right, 1934) . 
It was just at this time that the 
transmission of nerve impulses from motor nerve 
to striated muscle by acetyl choline was 
demonstrated (Dale, Feldberg and Vogt, 1936; 
Brown, Dale and Feldberg, 1936). Since 
acetyl choline and curare were also onium salts, 
it seemed likely that the action of onium salts 
in general was, like that of curare, an 
antagonism of the chemical transmitter at the 
motor end -plate. 
King (1935, 1936) isolated and crystallised 
an active principle ( +)- tubocurarine chloride 
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from crude tube curare, and found that it was a 
bis- tetrahydroisoquinolinium salt with 2 
quaternary nitrogen atoms. He later 
elucidated the complete structural formula 
(King, 1948). 
This finding together with the use of curare 
as a muscle relaxant during general anaesthesia 
(Griffith and Johnson, 1942) prompted the 
development of synthetic curare -like agents. 
Bovet and his co- workers investigated a number 
of onium salts, and succeeded in obtaining 
compounds with activity similar to that of 
curare. One of the first was a bis- quinolinium 
salt, 3381 RP (Bovet et al. 1946). 
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They then found that the quinolinium ring was 
not essential, and produced a number of 
simpler compounds, aromatic choline ethers, the 
most active being gallamine triethiodide 
(Flaxedil, F2559) (Bovet et al, 1947) 
OCk1lCkÑ 
The paralysis caused by gallamine could be 
easily reversed by eserine, and it was suitable 
for clinical use due to its absence of 
secondary effects. A large number of other 
compounds was synthesised in an attempt to 
relate chemical structure to curare -like activity, 
and to find more clinically useful drugs (see 
Bovet, 1951). In general, it was found that 
the oxygen bridge present in ( +)- tubocurarine, 
gallamine etc. was not essential, and that 
activity was greatest when two quaternary 
ammonium groups were present. 
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6SimD1e bis -onium salts 
Meanwhile some more satisfactory methods of 
testing neuromuscular blocking agents had 
become available, and Barlow and Ing (1948a and 
b) used the rat phrenic nerve- diaphragm 
preparation (Bülbring, 1946; Chou, 1947) and 
the rabbit head -drop test of Holaday to test 
simple polymethylene bis -onium salts. 
They tested bistrimethylammonium dibromides 
of the general formula 
Br (CH3 )3 N (CH2 )n N(CH3 )3 Br- 
where n = 2,3,4,5,7,8,9,10,11, 12 and 13 (BTMn) 
and bistriethylammonium dibromides of the 
general formula 
Br (C2B6 )3 N(CH2 )n N(C2i )3 Br 
where n = 2,3,4,5,7,8,9,10 and 13 (BTEn) 
and also some bis- strychninium, bis -quinolinium 
and bis- (phenyldimethylammonium) dibromides. 
On the rat diaphragm, the BTM series showed 
a gradual rise in activity from BTM3 -9, BTM 9, 
10, 11 and 12 being about equiactive, and BTM 
13 slightly less active. In the BTE series, 
there was a steady rise in activity from BTE 
4 -13, BTE 13 being slightly more active than 
BTM 9. In the rabbit head -drop test, 
however, there was a pronounced maximum in the 
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BTM series at BTM 10, this being three times 
as potent, weight for weight, as ( +)- tubocurarine 
while BTE 13 was 40% active as ( +)- tubocurarine. 
None of the members of the other three series 
was as active as the most active BTM compounds. 
It was suggested that the high activity of 
BTM 10 might be due to the possession of two 
quaternary nitrogen atoms separated by ten 
carbon atoms, since in ( +)- tubocurarine the 
shortest route between the nitrogens traversed 
ten atoms (nine carbon, one oxygen) (Barlow 
and Ing, 1948). 
The trimethylammonium series had also been 
studied by Paton and Zaimis (1948a and b) and 
BTM 10 was introduced into clinical use as 
a substitute for curare with the name of 
decamethonium. In 1949 Paton and Zaimis 
published an extensive study of the properties 
of the BTM series (n= 5 - 12, 18) testing 
neuromuscular blocking activity on the cat 
anterior tibialis preparation. They found 
a distinct maximum at BTM 10, and though (when 
the drugs were tested by other methods on 
other species) the potency varied, the maximum - 
was always at BTM 10. 
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It was noted that with BTM 10 there was a 
preliminary potentiation of the twitch and 
fasciculations of the muscle before block 
occurred, and it was later shown that BTM 10, 
like acetylcholine, could depolarise the motor 
end -plate (Burns and Paton, 1951; see preceding 
section). 
The series of compounds was also tested 
on the superior cervical ganglion preparation, 
where it was found that there was a maximum 
in ganglion- blocking activity at BTM 6; on the 
frog rectus, where some members were found to 
cause a contracture, with an apparent maximum 
at BTM 12 (members immediately above BTM 12 
were not tested; some of the lower members 
acted as antagonists to this contracture 
production); on the guinea-pig gut, where 
weak muscarine -like activity, increasing to 
BTM 12, was found; and on cholinesterase, where 
they had inhibitory activity against true 
cholinesterase, increasing with chain length 
(Paton and Zaimis, 1949). Thus it can be 
seen that these onium compounds have a 
considerable range of activity, at the same 
sites as acetylcholine. 
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( Compounds related to decamethonium 
Many compounds related to decamethonimm 
have been synthesised and tested in an effort 
to elucidate structure- action relationships. 
As well as being tested for blocking activity, 
many have also been tested for 'acetylcholine - 
like' activity as possessed by decamethonium, 
the criterion usually being the ability to 
produce a contracture of the frog rectus 
abdominis muscle. Actually activity on the 
frog rectus is not maximal at BTM 10 - BTM 11 and 
12 are both more active, and though BTM 18 is 
less active, it is not known where the actual 
maximum lies (Paton and Zaimis, 1949). Any 
changes in the onium groups of BTM 10 e.g. 
replacement of methyl groups by ethyl or amino, 
replacement of quaternary ammonium by 
quaternary phosphonium, seem to result in a 
decrease in 'acetylcholine -like' activity, and 
usually in neuromuscular blocking activity as 
well (Barlow, 'Introduction to Chemical 
Pharmacology') . 
The chain joining the onium groups can be 
altered e.g. by replacement of part of the chain 
by a benzene ring, or of a methylene group by an 
ether oxygen atom, and compounds are still 
obtained whose activity is similar to, and of 
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the same type as that of BTM 10 (Barlow, 
'Introduction to Chemical Pharmacology'). 
The compound 'Prestonal' is interesting because 
it is said to block at least partly by 
desensitisation (Frey, 1956), though it has a 
much longer chain than BTM 10 and also has a 
pair of methyl groups replaced by larger 
propoxycarbonylmethyl groups - this type of 
replacement usually leads to abolition of 
'acetylcholine -like' activity. 
When parts of the methylene chain are 
replaced by ester groups, compounds of the 
general formula shown below are obtained, and 
these are more active than BTM 10 on the frog 
rectus. 
(CH3 )3 NCH2 CH2 C00(CH2 )nC00CIi2 CH2 N(CH3 )3 
The compound of greatest interest is 
suxamethonium (succinylcholine) where n = 2 - 
this represents a doubling of the acetylcholine 
molecule. 
1CooCli 
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The higher members are still more active on the 
frog rectus but not in the rabbit head -drop test. 
Suxamethonium is the compound used clinically, 
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where its brief duration of action, due to 
hydrolysis by cholinesterase, makes it very 
suitable (Bovet et al, 1919; Castillo and de 
Beer, 1950). 
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ç_)Replacement of methyl by ethyl groups 
Changes in activity of onium compounds as 
N- methyl groups are replaced by ethyl have also 
been studied. Holton and Ing (1949) and Ing 
(1949) investigated analogues of acetylcholine 
itself, and Wien and Mason (1951, 1952) tested 
polymethylene bis -onium compounds with chain 
lengths of 4,5,6, and 7. Analogues of deca- 
methonium were studied by Barlow, Roberts and 
Reid (1953) and a considerable number of bis- 
onium compounds were studied by Ginzel, Klupp 
and Werner (1951) and Thesleff and Unna (1954) , 
who noted that not only the activity but also 
the apparent mode of action could be changed 
by replacement of methyl groups by ethyl. No 
consistent pattern of activity change with 
alteration of N- substituents has emerged from 
these investigations, but it must be remembered 
that compounds were tested at a variety of 
different sites, and that sometimes stimulant 
and sometimes inhibitory activity was measured. 
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B.THE AUTONOMIC GANGLION 
In addition to blocking transmission at 
the neuromuscular junction, onium salts can 
also affect transmission at autonomic ganglia. 
Burn and Dale (1915) found that tetramethyl- 
ammonium (TMA) on the cat usually caused a 
fall in blood -pressure with slowing of the heart, 
but when this muscarinic effect was abolished 
by atropine, TMA caused a rise in blood -pressure, 
followed by a fall. This was annulled by a 
large dose of nicotine, and so the pressor 
effect of TMA was a nicotine -like stimulation 
of sympathetic ganglion cells, followed by a 
nicotine -like paralysis of ganglia. Tetra - 
ethylammonium (TEA), on the other hand, showed 
no muscarinic actions and no pressor effect on 
the blood -pressure, but it did block the 
pressor action of TMA - hence it showed the 
secondary paralytic phase of nicotine action, 
without the stimulant action. 
Reid Hunt and Renshaw (1925) tested tetra - 
methylammonium, tetramethylphosphonium, tetra - 
methylstibonium and trimethylsulphonium, and 
found that while they all showed muscarinic 
effects, only the nitrogen, sulphur and 
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phosphorus compounds showed nicotine -like 
properties (tested on cat blood pressure). 
Reid Hunt (1926) tested tetramethylammonium 
and a large number of compounds related to it, 
with one or more of the methyl groups substituted 
by aliphatic or aromatic groups. He observed 
that the most marked stimulant nicotine -like 
action was obtained with compounds containing 
methyl groups, while the paralysing action of 
nicotine was obtained with many of the compounds, 
not limited to those containing methyl groups. 
Acheson and Moe (1945, 19)46) found that 
TEA caused a fall in blood -pressure in cats 
and dogs, and on investigation showed that it 
was not due to an effect on the heart, on the 
blood- vessels or on the vasomotor centres. 
The depressor effect was however dependent on 
a vasoconstrictor discharge, and they showed 
that it was due to blocking of the sympathetic 
ganglia - the nictitating membrane no longer 
responded to preganglionic electrical stimulation, 
but still responded to post -ganglionic stimula- 
tion. TEA did not possess the other actions 
of most onium salts - muscarinic, atropine -like, 
72. 
nicotinic, or curare -like - its predominant 
action was a ganglion blocking effect. 
Some bis- triethylammonivm compounds - 
BTE 2, 3, 4 and 10 -were compared with TEA on 
the perfused cat superior cervical ganglion 
by Chou and de Elio (1947). Like TEA, they 
blocked ganglionic transmission without 
preliminary stimulation. Activity dropped from 
TEA to BTE 2 and 3, then started to rise again, 
BTE 10 being twice as active as TEA. 
Paton and Zaimis (1949) studied the 
actions of members of the bis- trimethylammonium 
series (BTM 2 - 13, BTM 18) on the cat 
superior cervical ganglion preparation and on 
the Trendelenburg preparation for parasympathetic 
ganglia, as well as at the neuromuscular 
junction and various other sites. They found 
that BTM 5 and 6, which could cause a fall 
In blood- pressure, showed blocking activity at 
ganglia. Like TEA they blocked ganglia without 
prior stimulation, though their effect was 
more prolonged. They were twenty times as 
active as TEA, BTIV16being slightly more active 
than BTM 5. 
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Since ganglion- blocking agents can be 
used to treat successfully some cases of high 
blood -pressure, there has been an extensive 
search for clinically suitable drugs. The 
clinical disadvantages of hexamethonium itself 
are its e.ual effect on parasympathetic as well 
as sympathetic ganglia, and its unreliable 
oral absorption. Since quaternary salts 
have low lipid solubility, poor oral absorption 
is almost an inevitable corollary. Consequently, 
clinically useful drugs are more likely to be 
found among compounds containing secondary 
or tertiary amino groups, and having a suitable 
dissociation constant. However, considerable 
work has still been done on bis- quaternary 
compounds. 
The effect of alteration of substituents 
in the onium group depends on the length of 
the polymethylene chain - the particular onium 
group which confers optimum activity is 
different at different chain lengths. 
Various alterations in the chain have been made, 
but generally the most active compounds, whose 
activity is never much greater than that of 
hexamethonium, have a chain length similar to 
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hexamethonium. Some asymmetrical compounds 
were found to be more active than their 
symmetrical analogues, and also some dissocia- 
tion of activity at sympathetic and parasympa- 
thetic ganglia was obtained. A compound which 
was about eight times as active as hexamethonium 
was Chlorisondamine, a short -chain asymmetric 
compound, with one aliphatic onium group and 
one large halogenated aromatic onium group- 
(see Barlow 'Introduction_ to Chemical Pharmacolog 
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C. LONG -CHAIN POLYIvIETHYLENE BIS- TRIMETHYL AND 
BIS- TRIETHYLAMMONIUM SALTS 
It can be seen from the foregoing review 
that a considerable amount of work has been 
done on polymethylene bis- trimethyl and bis- 
triethylammonium salts. In particular, the 
shorter -chain BTM salts (BTM 3 - 13 and 18) 
have been extensively studied by Paton and 
Zaimis (1949), and there appeared to be a maxi- 
mum in ganglion blocking activity at BTM 6 
and in neuromuscular blocking activity at BTM 10. 
In the BTE series, the ganglion - blocking 
properties of 2, 3, 5 and 10 were described 
by Chou and de Elio (1947) and the neuromuscular 
blocking properties of BTE 2 - 5, 7 - 10 and 13 
were described by Barlow and Ing (1948). Both 
types of activity appeared to increase with 
chain length. 
The longer -chain BTE compounds (BTE 10 - 16) 
were tested on the cat superior cervical 
ganglion and on the rat diaphragm by Barlow 
and Vane (unpublished), and both types of 
blocking activity still seemed to be increasing. 
Mawer (unpublished) tested BTE 10 - 16 on the 
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rat diaphragm and found maximal blocking 
activity at BTE 15. BTE 9 - 17 were studied 
on a variety of preparations by 7iarrin_er (1960) 
and she found that ganglion blocking activity 
on the cat superior cervical ganglion was 
maximal at about BTE 16 and neuromuscular 
blocking activity on the cat tibialis maximal 
at about BTE 15. Atropine -like activity 
increased to BTE 17, while anticholinesterase 
activity did not vary much with chain length. 
Conductivity and surface tension were also 
measured to see if there was any gross change 
in conformation in solution with chain length, 
out there was no evidence of this. 
It was therefore considered desirable to 
repeat and extend Warrinerts experiments, 
using BTE 9 - 21, to confirm the position of 
maximum activity at about BTE 15 - 16, and 
1 so to study the long -chain BTM compounds, 
BTM 10 - 21, only a few of which had been 
tested previously. Also cross- sections at 
C10 and C16 were investigated, to find the 
effect of stepwise replacement of methyl groups 
by ethyl. 
77. 
The compounds were tested for ganglion - 
blocking activity on the cat superior cervical 
ganglion preparation, and for neuromuscular 
blocking activity on the cat tibialis preparation 
and the isolated rat phrenic nerve -diaphragm 
preparation. It was also desired to test 
them for acetylcholine -like 'depolarising' 
ability, and for this the chick biventer 
preparation (Ginsborg and 'arriner, 1960) 
was chosen. This muscle contains two types 
of fibre, one which responds to acetylcholine 
and 'depolarising' drugs like decamethonium 
by a contracture, and the other which gives a 
twitch in response to nerve stimulation and 
is blocked by neuromuscular blocking agents 
of either type. Ginsborg (1960) has shown 
that the contracture- producing fibre is multiply - 
innervated i.e. is supplied by a number of 
axons and has neuromuscular junctions distributed 
at many points on its surface, while the twitch 
fibre is supplied by a single axon with a 
focal end -plate. The end -plates in the multiply - 
innervated fibre are so close that an agent 
which causes depolarisation at the neuromuscular 
junction could be expected to produce a 
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relatively uniform depolarisation of the 
surface of this fibre, and so it seems likely 
that there is some association between ability 
to depolarise and ability to cause contracture 
of these fibres. This avian muscle was 
chosen in preference to amphibian muscle such 
as the frog rectus, which has similar diffusely - 
innervated 'slow' fibres responding with a 
contracture to 'depolarising' drugs, because 
of its greater sensitivity to these drugs and 
also because blocking of the twitch fibres can 
be observed concurrently on the same preparation. 
It was considered that these long -chain 
molecules might be able to fold or coil in 
solution, and that if this occurred suddenly 
at a certain chain -length, this might affect 
activity. Also, as polar molecules with a 
long hydrocarbon moiety, they might tend to 
form micelles, and this again could affect 
activity, by reducing the effective number of 
molecules in the solution. A physical 
measurement which would provide evidence, if 
any, of micelle formation or change in configura- 
tion in solution is conductivity, and 
measurements of conductivity were therefore 
performed. 
EXPERIMENTAL SECT ION 
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I. PREPARATIONS 
1. MEASUREMENT OF CONDUCTIVITY 
The conductivities of the solutions were 
measured using a Philips conductivity bridge 
(type PR 9500) and conductivity cell (type 
GM 4221). This consists essentially of a 
Wheatstone bridge using an alternating current, 
the resistance of a solution being measured 
between two parallel platinum plates mounted in 
the conductivity cell. 
The experiments were carried out using a 
series of stoppered Quickfit tubes suspended 
in a thermostatically - controlled constant - 
temperature bath, maintained at 25 ± 0.100. 
All solutions were made up with water from 
an Elgastat deioniser column, whose conductivity 
was around 1 x 10-15 mhos /cm. Resistances were 
measured for each compound at a minimum of 
3 concentrations and dilutions from the stock 
solutions (about 1 x 10 
-2 
M) were made up 
immediately prior to use, with deionised water 
whose resistance had just been measured. 
The experimental procedure was as follows. 
The conductivity cell was kept in a tube of 
deionised water, and was rinsed and allowed to 
remain in one for 15 minutes between each test 
solution. 3 tubes were filled with test 
solution, and the cell placed in one of them 
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while the other two were kept stoppered to 
decrease uptake of carbon dioxide from the 
atmosphere. They were left in the bath for 
X15 minutes so that temperature equilibration 
could take place and ions adsorbed on the 
platinum black electrodes could equilibrate. 
After equilibration one tube was unstoppered and 
the cell was transferred to it. 
It was left for 2 minutes and then the 
resistance read on the appropriate scale of the 
machine (position of minimum deflection). 
This process was repeated with the second tube 
as a check, and the average of the two values 
taken. 
The conductivity cell constant, given as 
1.33 at 25 °C, was checked using standard 
potassium chloride solutions, from the 
expression : - 
K 
r 
where K = cell constant 
R = specific resistance 
r = measured resistance 









In the case of dilute solutions, consideration 
'must also be given to the conductivity of the 
solvent 
31. 
x= K (r r rO) where r = measured resistance 
of solution 
ro= measured resistance 
of solvent 
Now molar conductivity =X- l000K 
where x = concentration in gm. moles/litre 
100x0 
K ( r - r ) (Findlay, 19L4.2 ) 
Molar conductances were calculated for 
various concentrations of potassium chloride and 
cetyltrimethylammonium bromide (CTAB). 
Standard curves were drawn of molar conductance 
against square root of molar concentration 
(X against 1 x ), since this should give a 
straight line if the Debye -Huckel equation is 
followed. This equation 
= %O- kJ where k = a constant for each 
substance 
x = ionic concentration 
in moles/litre 
= molar conductivity 
° at infinite dilution 
relates the molar conductivity at infinite 
dilution to the molar conductivity at any ionic 
concentration and was derived taking into 
account the asymmetry effect and the 
electrophoretic effect in the interionic 
attraction of electrolytes. The constant k 
is a complex expression, and the equation is 
only valid at high dilutions. 
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It was desired to obtain values for the 
molar conductance of each bis -onium compound at 
3 standard concentrations - 1.0 x 10 -2M, 1.0 x 
10-3M and i x 10-4M - so that these could be 
compared. When the solutions were made up by 
weighing out the exact quantity of solid 
required to make a 1.0 x 10-2M solution, and 
dissolving this accordingly the values of >\ 
were found to fluctuate somewhat. Since the 
crystals of these compounds tend to take up 
water easily and this might be introducing an 
error, during the weighing -out process, to the 
concentration factor in the above expression, 
it was decided to make up solutions of 
approximately 1 x 10-2M, and to obtain their 
precise normality by titration. The compounds 
are all bromides, and so the bromide was 
measured by Volhard estimation - 
precipitation of the bromide by standard silver 
nitrate in dilute nitric acid, and back 
titration of the excess silver nitrate by 
standard ammonium thiocyanate, using a ferric 
indicator (Vogel's 'Quantitative Analysis', 
p.348 -9). Having thus calculated the normality 
of the solution, the molarity was obtained by 
halving it, since the compounds are dibromides 
(with the exception of CTAB, a monob romi de, also 
estimated by this method). Further 
concentrations were obtained by diluting 
accurately these stock solutions of known 
normality. Graphs were drawn of X against 
fx , and from these the values of )\ for the 
exact desired molarities were obtained. These 
graphs also gave evidence, by their shape, 
of micelle formation, if any. 
2. THE CHICK BIVENTER CERV ICIS PREPARATIGN 
(Ginsborg and Warriner, 1960) 
Three -week old chickens were anaesthetised 
with ether. The back of the neck was plucked 
and the skin incised along the midline from the 
skull to below the base of the neck, exposing 
the 2 biventer 
was tied round 
which was then 
to the skull. 
cervicis muscles. A thread 
the upper belly of one muscle, 
cut free from its attachment 
The tendon and the lower belly 
of the muscle were dissected free, and removed 
together with the lower tendon, which attaches 
the muscle to the supraspinous ligament. 
A loop of thread was tied round the lower 
tendon and this loop was put round the hook at 
the bottom of the electrode assembly. The 
thread on the upper end of the muscle was 
passed through the electrode and attached to a 
light semi -isometric lever writing on a smoked 
drum. The electrode was lowered until it was 
in contact with the tendon surrounding the nerve. 
The 50 ml. organ -bath contained Krebs - 
bicarbonate solution at 37 °C, gassed with 95% 
oxygen and 57 carbon dioxide, via a sintered 
polythene distributor. The nerve was 
stimulated maximally at a frequency of 12 shocks/ 
minute. 
Figure 1: Contracture production on the chick biventer 
preparation: estimation of equipotent 
molar ratios compared to BTM 10. The 
following doses were given: 
(1) BTM 14 0.2 ml. of a 5 x 10-5M solution 
(2) BTM 10 0.1 ml. of a 1 x 10-4M solution 
(3) BTM 13 0.1 ml. of a 5 x 10 -5M solution 
(4) BTM 10 0.2 ml. of a 1 x 10 -4M solution 
(5) BTM 10 0.05 ml. of a 1 x 10-4M solution 
(6) BTM 13 0.2 ml. of a 5 x 10-5M solution 
(7) BTM 14 0.1 ml. of a 5 x 10-5M solution 
3. THE RAT PHRENIC NERVE -DIAPHRAGM PREPARATION 
(Bülbring, 1946) 
Rats of either sex weighing 150 -250 gms. were used 
They were killed by a blow on the head and bled 
out. The thorax was opened and the sternum and 
some ribs on the left side removed, exposing the 
diaphragm and the left phrenic nerve running up 
towards the thymus. A thread was tied round 
the phrenic nerve at the level of the thymus and 
it was cut and carefully dissected free down to 
the diaphragm. An incision was made through 
the left abdominal muscles along the costal 
margin, and a fan - shaped piece of diaphragm, 
together with 2 or 3 ribs, was removed - about 
3 mms. wide at the tendinous end and about 12 mms. 
wide at the costal margin. This was placed in 
Krebs -Henseleit solution in a Petri dish, and a 
thread was tied round the tendinous end of the 
muscle. 
The preparation was mounted on a hook pushed 
through the costal margin and suspended in a 
50 ml. bath containing Krebs -Henseleit solution, 
with double glucose, at 37 °C. The solution 
was gassed with 95% oxygen and 5% carbon dioxide 
via a sintered polythene distributor. The 
thread from the muscle was attached to a spring 
lever writing on a smoked drum, and the nerve 
86. 
was passed through the electrode. The nerve 
was stimulated maximally at a frequency of 
12 shocks /minute. 
Figure 2: Neuromuscular blocking activity on the 
rat phrenic nerve -diaphragm preparation: 
estimation of equipotent molar ratio 
compared to BTM 16. The following 
doses were given: 
(1) BTM 11 1.0 ml. of a 6.5 x 10-3M solution 
(2) BTM il 2.0 ml. of a 6.5 x 10 -3M solution 
(3) BTM 16 0.08m1. of a 8.2 x 10-3M solution 
(4.) BTM 16 0.04m1. of a 8.2 x 10-3M solution 
i37, 
4. THE CAT ANTERIOR TIBIALIS PREPARATION 
(Brown, 1938). 
Cats of either sex, weighing from 2 to 5 kg, 
were used. They were anaesthetised with ethyl 
chloride, and warm 1% chloralose, 80 mg/kg. was 
injected into the right femoral vein. A 
tracheal cannula was inserted. 
The left sciatic nerve was located between 
the ischial tuberosity and the great trochanter 
of the femur and was crushed by tying a thread 
round it, to deafferent the limb. The sciatic 
nerve, dividing into peroneal and medial 
popliteal nerves, was located in the popliteal 
space, and a Sherrington -type electrode placed 
on the peroneal nerve. 
then sewn up again. 
A hook was tied into the tendon of the 
anterior tibialis muscle close to its 
attachment on the inside of the foot, and the 
tendon insertion together with a knob of bone 
was cut out. The tendon was dissected free 
back to the muscle, cutting the annular 
ligament. The flexor tendon to the foot was 
cut. 
These incisions were 
The lower end of the fibula was cut off, 
exposing the flat part of the head of the tibia, 
and a drill -bar was screwed into this, 
J 8 
perpendicular to the outside of the leg. 
Another drill -bar was inserted, parallel to the 
first, into the flat part of the femur above the 
joint. 
The saphena vein was then ligated and 
divided, the fascia over the anterior tibialis 
muscle divided and the tendon raised. The 
anterior tibial artery was located lying 
beneath the muscle, separated and cannulated 
retrogradely, using the same needle cannula - 
2 -way tap set -up as was used in the superior 
cervical ganglion preparation. Saline was 
injected at intervals from a syringe inserted 
into the 2 -way tap, to prevent clotting. It 
will be noted that this is a modification of 
Brown's method - the vessels leading from the 
anterior tibial artery to the extensor longes 
digitorum and to the peroneal group were not 
tied, nor was a thread passed round the anterior 
tibial artery at the level of the interosseous 
membrane. The anterior tibialis has not 
therefore had its blood supply completely 
isolated, but the method used was considered 
adequate for present purposes. 
The animal was then fixed to the myograph 
stand by means of the drill -bars, with the 
tibia vertical, and the tendon hook was 
9. 
attached to a flat spring isometric recording 
myograph lever, writing on a smoked drum. A 
blood pressure record was taken by means of a 
cannula in the left or right carotid artery, and 
a mercury manometer. All exposed tissue was 
kept moist with liquid paraffin, and the animal 
kept warm by means of a lamp from above. 
The peroneal nerve was stimulated maximally 
at a rate of 12 /minute. 
Figure 3: Neuromuscular blocking activity on the cat tibialis 
preparation: estimation of equipotent molar ratios 
compared to BTE 16. The following doses were given: 
(1) MDE 16 15 nM 
(2) EDM 16 20 nM 
(3) BTM 16 30 nM 
(LE) BTE 16 6 nM 
Doses were given in approximately 0.2 ml. of 
solution. 
S = 0.2 ml. 0.9í6 saline 
90 
5. THE CAT SUPERIOR CERVICAL GANGLION PREPARATION 
(Trendelenburg, 1954; Paton and Perry, 1953) 
Cats of either sex, weighing from 2 to 5 kg., 
were used. 
In the earlier series of experiments, the 
cat was anaesthetised with ether in a box, then 
transferred to a warm table. The trachea was 
cannulated and was connected to a Wolff bottle 
containing ether. The right femoral vein 
was then exposed and cannulated and a 1% 
solution of chloralose, at 38 °C, was given 
slowly, in a dosage of 80 mg/kg. 
In the later series of experiments, the cat 
was anaesthetised with ethyl chloride on a mask, 
the right femoral vein exposed and warm 1-. 
chloralose, 80 mg/kg., given intravenously by 
syringe. The tracheal cannula was then 
inserted. This method was found to be 
wicker and to keep the animal in better 
condition. 
The tissues overlying the common carotid 
artery on one side, usually the right, were 
cleared, removing the lymph node and exposing 
the bifurcation of the external carotid artery 
and the lingual artery. A length of the 
pre -ganglionic sympathetic nerve was also 
exposed and freed, separating it from the vagus 
nerve. A. thread was put through the right 
nictitating membrane. The cat's head was 
immobilised by tying it to a transverse bar 
placed between the jaws and clamped firmly to 
the table. 
In the earlier series of experiments, the 
lingual artery and any branches of the external 
carotid were tied. The external carotid was 
tied peripherally, a remote - control bulldog 
clip placed centrally, and the artery 
cannulated between them, using a Luer syringe 
needle adapted as a cannula. The cannula and 
bulldog clip were clamped firmly in position. 
Injections could be made by inserting a 
syringe into the needle cannula, opening the 
bulldog clip and emptying the syringe. 
Injections of 0.2 ml. 0.9% saline were given 
at intervals to prevent clotting in the cannula. 
In the later series of experiments, the 
external carotid artery was tied off and the 
lingual artery cannulated retrogradely, using a 
needle cannula connected by a short length of 
fine polythene tubing to a Record needle. This 
was attached to a Record 2 -way tap, into which 
Syringes could be inserted. No remote -control 
2. 
bulldog clip was thus needed. The 2 -way tap 
was firmly clamped, and saline injections given 
at intervals. 
The preganglionic sympathetic nerve was 
divided and the central end laid over a probe 
electrode, which was also firmly clamped. 
The incision in the neck was then filled with 
liquid paraffin. 
A blood pressure cannula was inserted in the 
left femoral artery and a record taken by means 
of a mercury manometer and lever writing on a 
smoked drum, using heparinised saline as a 
connecting bridge. 
The nictitating membrane thread was passed 
over a pulley and attached to a light frontal 
writing lever, writing on the smoked drum, with 
a magnification of about 10 times. The 
preganglionic sympathetic nerve was stimulated 
maximally at a rate of 10 /second to produce a 
maximal contraction of the nictitating membrane. 
Stimulation was intermittent, approximately 
10 mins. on and 20 mins. off. 
Further doses of chloralose (about '/4 the 
original dose) were given every few hours to 
maintain anaesthesia. If a strychnine -like 
sensitivity to the chloralose developed, it was 
dispelled by a small dose of nembutal. 
Figure 4: Ganglion-blocking activity on the cat 
superior cervical ganglion preparation: 
estimation of eáuipotent molar ratios 
compared to BTE 16. The following 
doses were given: 
(1) BTE 16 18 nM 
(2) BTE 9 900nM 
(3) BTE 14 20 nE 
Doses were given in approximately 0.2 ml 
of solution. 
S = 0.2 ml of 0.9% saline 
7 
II. l,îETHODS 
The experiments were designed to measure 
changes in activity (agonist activity or antag- 
onist activity) throughout the two series of 
compounds. 
1. AGONIST ACTIVITY 
This was measured as contracture production 
on the chick biventer preparation, and was 
only given by a certain number of the compounds. 
Contractures were measured as the maximum 
deviation from the base -line. Each compound 
was compared with the standard ( decamethonium). 
Three or more different doses of either drug 
were given, and log dose -response curves were 
plotted (the time required for each dose 
precluded the performance of a full 4 -point 
assay; however, in trial runs it was found 
that responses were reproducible). From the 
log. dose -response curves, the equipotent molar 
ratio of the compound relative to decamethonium 
was calculated (i.e. the number of molecules 
of the test compound which produced the same 
effect as 1 molecule of decamethonium). Where 
94. 
the log dose -response curves were not parallel, 
the comparison was made at an arbitrary standard 
response level. A few of the less active 
compounds were tested by matching doses only. 
Each compound was tested on several preparations. 
Standard errors of the means of the equi- 
potent molar ratios were calculated for some 
of the compounds and the means for the different 
compounds tested for significant difference, 
using 'Student's t test'. 
For some of the compounds, the log dose - 
response curves were much less steep than that 
for decamethonium. To see if the compounds 
were acting as partial agonists, addition 
experiments were performed. Concentrations of 
the test compound and of decamethonium were 
found which produced the same effect. The two 
substances were then added simultaneously in half 
these concentrations, and if the contracture 
produced was less than that obtained previously 
the test compound was concluded to be a partial 
agonist (Stephenson, 1956). It does not follow, 
however, that if the contracture was the same 
size the compound was not a partial agonist. 
It is extremely likely that in this preparation 
the response is obtained with only a small 
95. 
proportion of receptors occupied. 
Decamethylene bis-acetoxyethyldimethyl- 
ammonium was also tested, in the presence of 
eserine, to see if it was appreciably hydrolysed 
by acetylcholinesterase under these conditions, 
as it is in vitro (Barlow, 1955). 
The drugs were added directly to the 
organ bath from a pipette in a small volume 
(usually 0.2 ml.). They were left in contact 
with the muscle until the effect had reached 
a maximum, which usually took about 10 min., 
then washed out and the preparation allowed to 
recover for 20 min. or until it had recovered 
fully, if this took longer. The interval 
between doses was thus usually 30 min. 
2. ANTAGONIST ACTIVITY 
This was measured as production of block 
of the muscle contraction resulting from nerve 
stimulation. Block was measured as the 
percentage reduction in height of the contract- 
ion (twitch or sustained contraction). Each 
compound was compared with a standard, and 
doses of the test compounds were found which 
96. 
gave degrees of block similar to that obtained 
with a certain dose of the standard i.e. pairs 
of doses of test and standard were obtained which 
gave matching responses. From these equipotent 
doses, the euuipoten_t molar ratio for each 
compound relative to the standard was calculated. 
(a) Whole Animal Experiments 
Due to the large number of compounds to 
- i 
be estimated on a limited number of animals 
and the length of time required for each dose, 
only one dose of each test compound was usually 
given in one experiment. Preliminary experiments 
were first carried out to find the appropriate 
concentration range for each compound. Since 
the sensitivity of these cat preparations 
increased markedly during the course of an 
experiment, it was desirable to have a dose of 
test compound always adjacent to a dose of 
standard. Doses were therefore given in the 
following pattern: S A B S C D S etc. where 
S = standard and A, B, C and D are test compounds. 
I 
It was intended to have as a standard response 
50% block of the contraction, but due to the 
97. 
varying sensitivity of a preparation, it was 
not always possible to achieve this. Each 
compound was tested on at least two animals. 
Drug doses were given by filling a Record 
syringe appropriately, inserting it into one 
limb of the two -way tap, opening the tap and 
injecting the drug via the arterial needle 
cannula. Drugs were given in doses of about 
0.2 ml. and were immediately washed in with 
0.2 ml. saline, from a syringe fitted in the 
other limb of the tap. The effect was allowed 
to reach a maximum, and then a further 0.2 ml. 
saline was injected. Sometimes this caused 
a slight further block, showing incomplete 
wash -out of the drug from the cannula etc. but 
this effect was never large. 
With the cat suoerior cervical ganglion 
preparation, intermittent stimulation was used. 
The dose of drug was given 3 min. after start- 
ing stimulation (by which time the contraction 
had reached a steady level), the effect was 
allowed to reach a maximum and then start to 
decline, and then the stimulation was switched 
off - a total of about 10 min. stimulation. 
98. 
The preparation was given about 20 min. 
recovery time, or longer if necessary for full 
recovery, saline being injected at intervals. 
With the cat tibialis preparation, 
continuous stimulation was used. The dose of 
drug was given as described above, and time 
for full recovery from the effect of the drug 
was allmed, as judged by the record on the 
drum, saline being given at intervals. 
(b) Isolated Tissue Preparations 
(i.e. chick biventer and rat phrenic- 
diaphragm) 
The doses of drugs were added directly 
to the organ -bath in a small volume (usually 
less than 0.2 ml). They were left in contact 
with the muscle until the block had reached a 
maximum (about 10 min.) then washed out, and 
the preparation left until full recovery had 
occurred - at least 20 min. The interval 
between doses was thus about 30 min. 
On the rat phrenic nerve- diaphragm 
preparation sufficient doses were given, when 
possible, to -prepare log dose- response curves, 





As mentioned in the Methods section, the 
molarity of each solution was checked by 
Volhard estimation of bromide. Table 1 shows 
the molarity calculated from the weight of 
material taken compared with the molarity found 
by titration. For the members of the BTE 
series the observed value for the molarity is 
always lower than the calculated value, usually 
by about 3%, and this discrepancy is presumably 
due to the absorption of water by the solids 
while being weighed out. For those members 
, of the BTM series for which a comparison was 
made, the discrepancy is less: these compounds 
are less hygroscopic than the members of the 
BTE series: BTM 17, 18 and 20, in fact, were 
very difficult to dissolve - solutions which 
were almost saturated had to be used. No 
explanation for this relative insolubility 
could be found. 
Graph 1 shows the standard curve of 
molar conductance against square root of 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































is linear at lo't concentrations and deviates 
from linearity as the concentration increases 
(above about 4 x 10-2M, in this estimation), 
when the Debye- Hi'ickel equation no longer holds. 
Graph 2 shows the standard curve of 
molar conductance against suare root of 
concentration for cetyl trimethyl ammonium 
bromide (CTAB), a surface -active compound which 
is known to form micelles. The curve shows 
three characteristic slopes: 
(1) at low concentrations it is linear, 
as for strong electrolytes, 
(2) it falls steeply - this is due to 
micelle formation, 
and (3) it flattens out again at high 
' concentrations. 
The concentration at the 'break- point' between 
parts (1) and (2) is called the critical micelle 
concentration i.e. the lowest concentration at 
which micelles just begin to form, and for 
CTAB it is here found to be 5.8 x 10-4M. In 
the literature, the curve given for cetyl 
trimethyl ammonium chloride (CTAC) is identical 
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micelle concentration for CTAC being given as 
1.3 x 10-3M (Ralston et al. , 1947). 
Graph 3 sho7: s curves of molar conductance 
against s,lua.re root of concentration for some 
of the test com-)ounds. Those for BTM 15 and 
19, and BTE 10 and 12 are typical linear graphs 
as for strong electrolytes. All the curves 
were of this type except for those of BTE 20 and 
21, BTM 21 and BTM 17, 18 and 20. BTE 20 and 
21 and BTM 21, as shown in the graphs behaved 
like CTAB in its two to :er concentration ranges. 
Thus it seems that micelle formation does occur 
with BTE 20 and 21 and BTM 21 as the concentration 
is increased, the critical micelle concentrations 
being 5.0 x 10-3M, 3.6 x 10-3M and 3.2 x 10 -4M 
respectively. Therefore, if these compounds 
are used in biological experiments at concentra- 
tions higher than these critical micelle 
concentrations, the activity may be affected by 
micelle formation, which will reduce the 
effective number of molecules present. 
BTM 17, 18 and 20 are the compounds which 
were difficult to dissolve, and they showed 
anomalous curves, of which that for BTM 18 is 
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molar conductance first rose sharply, then 
abruptly levelled off or actually decreased again. 
For BTM 18 and 20 it was found to have increased 
again at about 1 x 10-4M, but at this low 
concentration error due to uptake of carbon 
dioxide may be considerable. It seems unlikely 
that micelle formation could be the explanation 
for these curves, as BTM 19 shots no evidence 
of micelle formation. The abnormal low 
solubility and the abnormal conductance curves 
seem to be linked, but unfortunately no explana- 
tion cran be :)rovided. 
Table 2 and Graphs 4, 5 and 6 show the 
molar conductances at three standard concentra- 
tions for the compounds of the two series, and 
for some compounds with a chain length of 16 
methy] Fane groups but with different substituent 
groups on the nitrogen atoms. Graph 4 shows 
that molar conductance does not vary much with 
chain le nth in the BTM series - it decreases 
slightly and gradually with increasing chain 
length - with the exception of the anomalous 
results for BTM 17, 18 and 20, and micelle 
formation at the higher concentrations for BTM 21. 
TABLE 2.- Results of Conductivity 
Measurements. 
A B 
Compound % A %ß Xc Compound %A % a r ñc 
BTE 9 185 220 231 
BTM 10 204 236 246 BTE 10 184 217 228 
BTM 11 201 235 245 BTE 11 185 219 230 
BTM 12 196 225 235 BTE 12 185 212 221 
BTM 13 196 229 239 BTE 13 185 217 228 
BTM 14 195 227 237 BTE 14 184 220 232 
BTM 15 192 222 231 BTE 15 184 217 229 
BTM 16 193 25 235 BTE 16 183 213 222 
BTM 17 175 221 - BTE 17 182 213 224 
BTM 18 138 216 - BTE 18 180 215 226 
BTM 19 180 220 233 BTE 19 177 218 232 
BTM 20 173 217 - BTE 20 148 213 225 
BTM 21 157 224 239 BTE 21 118 212 230 
C 
Compound ñA Xß %C 
BTM 16 193 2 J 23J 
BEJM 16 183 213 221 
BìvDr; 16 185 212 220 
BTE 16 183 213 922 
BHD:,: lb 185 211 220 
BTM 16 192 220 229 
BDE 16 179 207 216 
::here ín A = molar conductance 
1.000x 10-2M 
Xa = molar conductance 
1.000 x 10-3M 
Xc = molar conductance 
1.000 X 10-4M. 
in mhos /cm at 
in mhos/cm at 
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Graph 5 shows that molar conductance is 
practically constant for the BTE series until 
micelle formation appears at the highest 
concentrations for BTE 20 and 21. The slight 
fluctuations in the values at the two lower 
concentrations while those at the highest 
concentrations ere steady is probably only due 
to experimental error (though they do tend to 
run_parallel, and in particular there is a slight 
drop in the results at concentrations B and C 
for the compounds in both series with a chain 
length of 12 methylene groups). 
The results for the BTE series, except 
for that obtained for BTE 15, are similar to 
those of Warriner (1960), who used uncorrected 
molarities. She obtained an unexpectedly 
high value and stated that it required to be 
checked. In this investigation the value for 
BTE 15 is quite normal, in accordance with its 
position in the series, and this suggests that 
the previous result was erroneous. The results 
for both series suggest that at no chain length 
is there any significant alteration in the config- 
uration of the molecule e.g. folding, which 
10)4. 
might affect the nh_.rmacological properties. 
rctivity may only be affected by micelle forma- 
tion in the highest members of the series, at 
relatively high concentrations. 
Graph 6 shows that the molar conductance 
of compounds with chain- length of 16 methylene 
groups does not change much with the variations 
in substituents on the nitrogen atoms tested 
here. The conductances of the bis- dirnethyl 
land the bis -trimethyl compounds are almost 
identical, there is a slight drop in conductance 
-,hen 1 or 2 methyl groups are replaced by ethyl, 
and a slight further drop when the third methyl 
is replaced by ethyl. The values for the bi s- 
hydroxyethyl dimethyl compound and the bis-ethyl- 
dimethyl compound are identical, as of course 
there is very little difference in their 
structures, snd there is another slight drop 
in conductance from the bis -triethyl compound 
to the bis -diethyl compound. It seems therefore 
that increasing the bulk of the cationic head 
tends to louer the conductance of the molecule 
slightly - the conductancesfor all members of 
the BTE series are lovíer than those for the 
corresponding members of the BTM series, in 
105. 
agreement with this. This result would be 
expected as increasing the bulk of the molecule 
will tend to decrease its mobility in solution. 
The difference between the values for correspond- 
ing members of the two series becomes less as 
the chain -length increases, presumably as the 
overall length of the molecule becomes a more 
important factor than the bulk of the cationic 
head. On this explanation, however, the lower 
conductance of the bis- diethyl compound than 
the bis- triethyl comoound is unexpected. 
106. 
2. ACTIVITY AT THE NEUROMUSCULAR JUNCTION 
A. Chick Biventer Preparation 
(1) Contracture Production. - The activity 
of the compounds in producing contracture of 
the chick biventer preparation is summarised 
in Tables 3 and 4 and Graphs 7, 8, 9 and 10. 
The values are expressed as mean equipotent 
molar ratios + standard error (EPMR + SE), 
and also as rncan log equipotent molar ratios 
+ standard error (log EPMR + SE), since the 
distribution of ratios is probably logarithmic 
(Gaddum, 1945). 
In the BTM series (Table 3A) contractures 
were obtained easily with BTM 10 - 16. Each 
compound was compared to BTM 10 = 1.0 and it 
was found that BTM 11 is more active than 
BTM 10 and BTM 12, and BTM 13 is the most 
active. The activity decreases from BTM 14 -16. 
The means of the equipotent molar ratios were 
tested for significant difference using Student' S 
't' test, at the 0.05 level of probability. 
The values for BTM 10, 11, 12 and 13 are 
significantly different, and so are the values 
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difference between the values for BTM 13, 14 
and 15. However, it seems likely that BTM 13 
is in fact the most active, since the lack of 
significant difference from BTM 14 and 15 is 
mainly due to the high standard error of the 
means for the latter two. This resulted from 
deviations from parallelism between the log 
dose- resoonse curves for BTM 10 and the 
higher members of the series. The log dose - 
response curves became flatter, compared to 
that for BTM 10, as the chain length increased, 
and the determinations of equipotent molar 
ratio were made at an arbitrary standard 
response level. 
The higher members of the series, BTM 17 - 
21, could produce small contractures when 
high doses were given, but the log dose -response 
curves were very flat and maximal contractures 
could never be obtained - evidently they are 
only :partial agonists. 
In the BTE series (Table 3B) contractures 
could only be obtained with BTE 10, 11 and 12. 
This confirms Warriner's purely qualitative 
results (1960). BTE 11 and 12 have similar 
108. 
activity, about three times that of RTE 10, 
with which they were compared. 
:'there the composition of the onium groups 
in the ,ieca.methylene compounds is altered 
(Table liA: Barlow and Zoller, 1962), replace- 
ment of methylgrou+ s by ethyl decreases the 
activity in a stepwise fashion. Replacement 
of one methyl group by hydroxyethyl or acetoxy- 
ethyl has more effect than replacement by ethyl. 
Removal of one methyl grcu.p, producing a 
tertiary compound, reduces the activity to 
the greatest extent. 
The log dose -response curve for BTE 10 
was much flatter than that for BTM 10, and 
addition experiments indicated that it is a 
partial agonist (the value in Table LA was 
obtained using only threshold. responses). 
Addition was demonstrated for BEDM 10, BMDE 10, 
BHDM 10 and BDM 10, but does not, of course, 
necessarily mean that they are not partial 
agoni st s. 
The effects of BADM 10, which is hydrolysed 
by acet:lcholinesterase in vitro (Barlow, 1955), 
were not potentiated by eserine (in concentra- 
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to be destroyed to tiny extent by the cholin- 
esterases in this preparation. This justifies 
the inclusion of the results for BADM 10 in 
Table 4A, since they were obtained without 
e Seri ne being present. 
When the composition of the onium group 
in the hexadecamethylene compounds is altered 
(Table 4B), replacement of one methyl group 
by ethyl reduces the activity, and replacement 
of more methyl groups virtually abolishes 
ability to produce a contracture altogether. 
Replacement of one methyl group by hydroxyethyl 
also virtually abolishes activity. On the 
other hand, removal of one methyl group from 
BTM 16 or one ethyl group from BTE 16 to give 
tertiary compounds results in an apparent 
retaining of the ability to produce contracture. 
However, this contracture is delayed in onset, 
increases slowly and apparently continuously, 
and recovery after washing is very slow indeed. 
This suggests a different mode of action 
probably a direct action on the cell and 
possibly a penetration of the cell membrane 
by the unionised form of the tertiary compounds. 
110. 
The concentration of BTM 10 in the bath 
fluid in these experiments was usually about 
1 x 10-7M. With BTM 10 there was seldom any 
blocking of the twitch concurrently with the 
contracture, but as the chain length increased 
there was an increasing component of twitch 
block together with the contracture. If the 
drug was left in for a long time the contracture 
would begin to pass off without washing out, 
even with BTM 10. 
(2) Blocking activity.- Blocking activity 
on the chick biventer twitch was determined for 
the BTE series, most of which did not produce 
a contracture. Contracture was obtained some- 
times, but not always, with BTE 10, 11 and 12, 
and also sometimes with BTE 17, 20 and 21. 
Whether or not contracture was obtained seemed 
to depend to some extent on the tension of the 
muscle - it is possible that under the right 
iconditions some degree of contracture might 
have been obtained with all the BTE series, 
but they would certainly only have been partial 
agonists. 
The results are summarised in Table 5 and 
Graph 11, expressed as equipotent molar ratios 
compared with BTE 16: the mean is shown with 
the standard error. Blocking activity increases 
from BTE 9 to a maximum at BTE 15 - 16, then 
decreases again, BTE 20 and 21 being almost 
inactive as blocking agents. 
The usual concentration of BTE 16 in the 
bath fluid required to produce incomplete block 
was about 5 x 10-7M. 
TABLE 5.- Activity of Compounds on Chick 
Biventer Preparation: Antagonist Activity. 
Compound EPMR + SE log EPMR + SE No. of 
eXrts. 
BTE 9 37 + 2.6 1.57 + 0.03 3 
BTE 10 33 + 0 1.52 + 0 4 
BTL 11 9.2 + 0. L 0. 96 + 0.02 3 
BTE 12 6.1 + 0.3 0.79 + 0.02 3 
BTE 13 _).3 + 0 0.52 + 0 3 
BTE 14 1.3 + 0 0.11 + 0 3 
BTE 15 1.0 + 0 0.00 + 0 3 
BTE 16 1.0 0.00 - 
BTE 17 1.3 + 0 0.11 + 0 4 
BTE 18 6.1 + 0. Lt 0.76 ± 0.03 3 
BTE 19 69 + 7.3 1.84 ± 0.05 3 
BTE 20 > 300 > 2.5 
BTE 21 > 500 > 2.7 
Equipotent molar ratio (EPMR) + standard error 
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B. Rat Phrenic Nerve -Diaphragm Preparation 
Blocking activity on the rat diaphragm 
twitch was determined for the BTM series. 
The results are summarised in Table 6, Graphs 
12 and 13. They are expressed as equipotent 
molar ratios compared with BTM 16: the mean 
is shown with standard error. These values 
were obtained from log dose -response curves. 
Log equipotent molar ratios are also shown. 
Blocking activity decreases from BTM 10 - 12, 
then increases again, with a maximum at BTM 17. 
The rat diaphragm is less sensitive to these 
compounds than the other test preparations used: 
the usual concentration of BTM 16 in the bath 
fluid required to produce partial block was 
about 1 x 10-5M. The longer members of the 
series, BTM 19 - 21, are feeble blocking agents 
and the high bath concentrations required 
proved to be toxic to the muscle; they caused 
an irreversible shortening of the muscle fibres. 
TABLE 6 .- Rat phrenic diaphragm preparation: 
antagonist activity of compounds. 
Compound EPMR + SE log EPMR + SE No. of 
expts. 
BTM 10 9.8 + 1.4 0.98 + 0.06 3 
BTM 11 10 + 1.9 1.00 + 0.08 3 
BTM 12 15 ±1.6 1.10 + 0.05 3 
BTM 13 8.9 + 0.6 0.95 + 0.03 3 
BTM 14 6.5 + 1.5 0.91 + 0.09 3 
BTM 15 2.0 + C. 1 0.)111 + C.02 4 
BTM 16 1.0 0.00 - 
BTM 17 0.0 + C.2 -0.27 + 0.15 3 
BTM 18 1. 5+ G.2 0. 1 7+ 0.05 3 
BTM 19 toxic - - 
BTM 20 toxic - - 
BTM 21 toxic - - 
Equipotent molar ratio (EPMR) + standard 
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C. Cat Anterior Tibialis Preparation 
The neuromuscular blocking activity 
of the compounds on the cat tibialis is 
sammarised in Tables 8, 9 and 10 and Graphs 16, 
17 and 18. 
In the BTM series, where each member was 
compared with BTM 16 (Table 8), activity is 
initially high at BTM 10, declines to BTM 14, 
then increases again to a second maximum at 
BTM 18 (though this is lover than that at BTM 10)., 
After BTM 18 activity decreases again. Paton 
and ZED imi s (1949) also found that BTM 11 and 12 
were less active than BTM 10, but they found 
that BTM 18 was less active than BTM 12, contrary 
to the present result. 
In the BTE series, where each member 
was compared with BTE 16 (Table 9) activity 
increases from BTE 9 steadily to a maximum at 
BTE 16 - 17. This confirms Varriner's results 
(1960). It was considered that one value for 
each compound would be sufficient if the 
previous findings were confirmed. This means, 
however, that standard errors and log values 
could not be calculated for these compounds. 
TABLE 8 .- Cat anterior tibialis preparation: 
antagonist activity of compounds. 
Compound EPMR + SE log EPMR + SE r?o. of 
expts. 
BTM 10 0.4 + 0.1 -0.47 + 0.12 3 
BTM 11 0.9 + 0.7 -0.25 + 0.L15 2 
BTM 12 1.3 + 0.3 0.09 + 0.09 2 
EsTM 13 1.6 + 0.4 0.19 ± 0.11 2 
BTM 14 1.6 + 0.2 0.21 + 0.(7) 
BTY 15 1.3 + 0.2 0.11 + 0.06 z 
BTM 16 1.0 0.00 _ 
BTM 17 0.9 + 0.1 -0.06 +0.06 3 
BTM 18 0.8 + 0.2 -0.15 + 0.1.1 3 
BTM 19 1.3 +0.0 0.10 +0.01 2 
BTIvI 20 1.7 + 0./1 0.21 + 0.10 2 
BTM 21 3.0 + 0.0 0. L.8 + 0.00 2 
Equipotent molar ratio (EPMR) + standard 
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Unfortnately, an anomalous result was obtained 
for BTE 10, three detelminations with different 
solutions being inconsistent, but all higher 
than expected. Above BTE 17, activity decreases 
again, falling sharply at BTE 20. 
'.fl en the composition of the onium group 
in the hexadecamethylene compounds is altered, 
(Table 10: each compound was compared with 
BTE 16) activity decreases stepwise from BTE 16 
to BTM 16, by an overall factor of 5. This 
means that in fact BTE, 16 is slightly more 
active than BTM 10. It was also about 8 times 
I 
as active as ( +)- tubocurarine. 
The dose of BTE 16 injected was usually 
about 0.2 ml. 5 x 10-5M i.e. 10 nanoMoles, and 
assuming an approximately 100 -fold dilution in 
the blood as it reaches the ganglion (c.f. 
Barlow and Hamilton, 196.2), this gives a 
similar concentration (1 x 10-7M) to that found 
to block the chick biventer. 
With doses sufficient to produce complete 
block on the tibialis twitch, ne effect on the 
blood- pressure was ever observed. 
TABLE 10 .- Cat Tibialis: Antagonist activity 
of compounds. 
Compound EPMR + SE log EPMR + SE No. of 
exots. 
BTE 16 1.0 0.00 - 
BMDE 16 2.5 0.40 1 
BEDM 16 2.9 + 0.4 0.46 + 0.06 2 
BTM 16 5.5 + 0.5 0.74 + 0.04 2 
dTC 6.0 0.90 1 
Equipotent molar ratio (EPMR) + standard 
error relative to BTE 16 
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3. ACTIVITY AT THE AUTONOMIC GANGLION 
Cat Superior Cervical Ganglion Preparation 
The ganglion blocking activity of the 
compounds on the cat superior cervical ganglion 
preparation is summarised in Tables 11, 12 and 13 
and Graphs 19, 20 and 21). 
In the BTM series (Table 11) where each 
compound is compared with BTM 16, BTM 11 is 
less active than BTM 10(which is in turn less 
active than BTM 6, hexamethonium) but activity 
then increase again to a maximum at BTM 16 - 18. 
Above this it starts to fall off again, but 
slowly, BTM 21 being slightly more active than 
BTM 11 and 12. The range of activity for all 
the compounds of this series, however, is only 
ten -fold. 
In the BTE series (Table 12: each 
compound is compared with BTE 16) activity 
increases from BTE 9 to a maximum at BTE 17. 
The figures agree quite well with those of 
Warriner (1960) for BTE 12 - 17. Above 
BTE 17, activity drops off again, rather more 
sharply than in the BTM series. The overall 
range of activity for the BTE series is nearly 
a hundred -fold. 
TABLE 11.- Cat superior cervical ganglion 
preparation: antagonist activity of compounds 
Compound EPMR + SE log EPMR + SE No. of 
EXpts. 
BTM 10 ü. 5+ 1.5 0.92 + 0.08 2 
BTY 21 l6 + 3.5 1.21 + n.10 2 
BM: 12 14 + 1.0 1.15 + 0.03 2 
3TI, : 13 8.5 + 1.5 n.:-,2 + n.03 2 
-L,f7 : 1- 4.5 ± 0.5 0.65 + 0.05 2 
BTir_ 15 1.4 + 0.1 0.15 + 0.03 2 
3`2:.: 1 1.0 0.00 - 
.Tl'I.i 17 1.0 + 0 0.00 2 
3TL 18 0.9 + 0.1 -r.:5 + 0. 05 2 
T 1 9 g 2.0 + 0 0. 30 + 0 2 
:311r7 20 L.5 + 1.5 `-'n v3 + 0.15 2 
BTM 21 11 + D 1,011 + 0 2 , 
Eçuipotent molar ratio (EPMR) + standard error 
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116. 
Then the composition of the onium group 
in the hexadecamethylene compounds is altered 
(Table 13: each com2oirnd is compared with 
BTE 16) there i. s very little alteration in 
clivi ter as methyl groups are replaced by ethyl 
groups. All the C16 compounds are about five 
times as active as hexamethonium (BTM 6), and 
their action is more prolonged. 
The usual dose of BT: 16 injectedwas 
about 0.2 ml. 5 x 10-5M i.e. 10 nanoMoles. 
Even with dosessufficient to produce complete 
block of the response of the nictitating membrane, 
there were usually no effects on the blood - 
pressure. However on two occasions a rise in 
blood -pressure was obtained after fairly large 
doses of BTM 10 - possibly due to adrenaline 
release from the adrenals. There was no 
evidence of stimulation of the ganglion by any 
of the compounds. 
TABLE 13.- Cat superior cervical 
ganglion preparation: Antagonist 
activity of compounds 
Compound EPMR + SE No. of 
expts. 
BTE 16 1.0 - 
BRIDE 16 1.5 1 
BEDM 16 1.6 1 
BTM 16 1.3 + 0.2 2 
BTM 6 5.0 1 
Equipotent molar ratio (EPMR) + standard 
error relative to BTE 16 
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DISCUSSION 
Assessment of the Information Available from the 
Results 
It is necessary to consider how far the 
results obtained really indicate the true 
activity of the compounds on junctional trans- 
mission and how far they may be affected by 
other properties. With these chemically inert 
molecules it is unlikely that there will be any 
extensive metabolism of the drugs in the experi- 
ments. Even differences in rates of elimination 
of the drugs from the blood, which would 
complicate the experiments using intact prepara- 
tions, should not seriously influence the results 
because both in the cat tibialis and cat 
superior cervical ganglion experiments the 
injections were made very close to the site 
of action of the drug. 
In calculating the results it has been 
assumed that the time course of the effects 
produced by the drugs is the same for all. 
If two drugs do not produce effects with 
comparable time courses it is not possible to 
compare their activities and express the result 
as an equipotent molar ratio. It is also only 
118. 
possible to do this if their log dose -response 
curves are parallel. With the longer members 
of the series neither of these criteria appears 
to hold. There is a gradual increase in the 
length of action of the compounds as the chain 
length increases, but this does not become 
really marked until the chain length is around 
18 or 19 methylene groups and the activity is 
beginning to decline. The same seems likely 
to be true for the log dose -response curves - 
on the chick biventer the curves begin to be 
noticeably flatter than that for BTM 10 at 
about BTM 15 - 16, but agonist activity is 
already declining at this chain length; on the 
rat diaphragm the log dose -response curves of the 
compounds appear to be more or less parallel until 
BTM 18 is reached and at this point the antagonist 
activity starts to decline. 
On the cat preparations comparisons were 
made only at one dose level so it is not possible 
to say whether the log dose -response curves for 
the standard and test drugs were parallel or not. 
However the level of response at which the 
comparisons were made varied considerably from 
experiment to another yet the equipotent molar 
119. 
ratios obtained were reasonably consistent. 
This suggests that the log dose -response curves 
must have been at least approximately parallel. 
The most serious factor likely to 
complicate the results is their modification 
by inhibition of acetylcholinesterase. A 
full study of the effects of these compounds 
on acetylcholinesterase has unfortunately not 
been made but the experiments of Paton and 
Zaimis (1949) and of Bergmann and Segal (1954) 
on the trimethyl series indicate that inhibitory 
activity increases with chain length up to 
BTM 12, and that BTM 18 is less active than 
BTM 12. From Bergmann and Segal's results 
it would appear that -log ki for BTM 12 is 
6.20 i.e. that a concentration of 10 6.20 of 
this compound would produce 50% inhibition of 
the rate of hydrolysis of acetylcholine when 
the enzyme is half- saturated. This suggests 
that anticholinesterase properties might be 
complicating the results if the concentration of 
BTM 12 used in the experiments is greater than 
about 10-6M. Between BTM 12 and BTM 18 the 
anticholinesterase activity is not known but 
one experiment with BTM 14 indicated that this 
120. 
compound is less active than BTM 12. The 
situation is unsatisfactory (and will be 
remedied when time permits) but it seems 
reasonable to suppose that if compounds are 
active in pharmacological experiments in 
concentrations less than 10-6M, anticholinesterase 
activity is not likely to complicate the 
results. As shown in Table 14 , only the 
less active compounds are present in concentra- 
tions where anticholinesterase activity might 
be a complicating factor, except on the rat 
diaphragm preparation. In this experiment, 
acetylcholinesterase inhibition might well be 
occurring, and in fact in one experiment 
potentiation of the twitches by a small dose 
of BTM 11 was observed. 
Compounds of the BTE series were studied 
by Warriner (1960) who obtained results which 
indicate that - log ki for BTE 12 is 5.86 and 
that the activity does not alter much between 
BTE 12 and BTE 17. These results are further 
grounds for assuming that activity in the BTM 
series does not alter greatly between BTM 12 and 
BTM 18 (though this is no excuse for not doing 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































anti- acetylcholinesterase activity is not 
likely to complicate effects produced by the 
BTE compounds in concentrations less than 
10-6M, and as shown in Table 14+, again only 
the less active compounds are present in 
concentrations greater than this. 
Another factor which may influence the 
results for the longer compounds is the forma- 
tion of micelles. This would lead to a 
discrepancy between the true amount of compound 
present in solution and the total amount 
present (both in solution and as micelle). 
The conductivity experiments indicate that the 
critical micelle concentration is around 
3 x 10-4M for BTM 21 and 4 -5 x 10 -3M for BTE 20 
and 21. In fact concentrations as high as 
this were never used in the pharmacological 
experiments (Table 114. 
It seems possible however that the surface 
activity of some of the compounds on the cells 
and for receptors may account for certain of 
their pharmacological properties. For instance 
in the experiments on the rat diaphragm with the 
higher members of the BTM series (BTM 19 - 21), 
effects were only produced by concentrations 
122. 
which caused an irreversible shortening of the 
muscle fibres. These compounds were only 
feeble neuromuscular blocking agents and this 
toxic action could easily be ascribed to, and 
is definitely associated with, their surface 
activity. The same effect was obtained with 
cetyltrimethylammonium bromide. 
In general, then, it seems likely that the 
results observed are due to the effects of the 
compounds on the receptors and not to other 
causes. 
123. 
Comparison of the Activities of the Compounds 
In the results section the activities of the 
compounds are all expressed relative to a 
standard chosen from within the particular 
series being studied. The purpose of this was 
to try to avoid comparing drugs which might be 
acting in different ways. It is, however, 
interesting to compare the activity of all the 
compounds together. 
Values for the agonist activity of the 
compounds on the chick biventer, all expressed 
relative to BTM 10, are shown in Table 15 . 
These show quite clearly that agonist activity 
depends greatly on the presence of a trimethyl- 
ammonium group and, to a lesser extent, on chain 
length. 
Replacement of even one methyl group in 
BTM 10 by ethyl in each cationic head reduces 
activity to about one -third and the replacement 
of a further methyl group markedly reduces 
activity. Replacement of one methyl group in 
each cationic head by hydrogen (as in BDM 10) 
also markedly reduces activity. Yet nevertheless 
bistriethyl compounds will cause contracture if 

















































































































































































































































































































































































































































































































































































































































































































groups. It is interesting that the bis- hydroxy- 
ethyldimethylammonium compound, an analogue of 
choline, is much less active than the ethyl - 
dimethylammonium compound; the introduction 
of the hydroxyl group in fact reduces agonist 
activity 50 -fold or more. What is even more 
surprising is that the acetoxy compound is less 
active still. 
Similar, though more drastic, effects 
are found when methyl groups in BTM 16 are 
replaced by ethyl. Replacement of one methyl 
group reduces activity to about one -twentieth, 
and further replacement virtually abolishes 
activity. The bis -hydro xyethyldimethylammonium 
compound is also virtually inactive - intro- 
duction of the hydroxyl group here reduces 
activity even more than in the decamethylene 
compounds. 
In conclusion then, it seems possible that 
for compounds of this type to be active they must 
be long (within limits) and thin molecules. 
So far as antagonist activity on the 
neuromuscular junction is concerned, the 
results (Tablel6A, Graph as ) suggest that 






































































































































































































































































































































































































































































































































































S MDE /6 
0--0 Serr,e-S 
/o r! /2. 13 ik iS i4 iy i8 i9 lo ! 
CO q`rO.\^S 6 
°1` 
11`' \ v \ 
+z_c\`_xirke vv.k \*Zo. 
Os-jC w Ov css3c 
125. 
way from the BTE compounds, particularly those 
with chain lengths of around 10 - 14 methylene 
groups. Above this chain length it is unlikely 
that the BTM compounds are acting like BTM 10. 
This point is illustrated in Table 17 in which 
the ability to produce block on either the rat 
diaphragm or the cat tibialis is compared with 
the ability to produce contracture on the chick 
biventer (all expressed relative to BTM 10). 
If this ratio is greater than one, then the 
compound is present at the neuromuscular junction 
in a concentration which should be capable of 
acting like decamethonium (assuming that the chick 
biventer gives a reliable measure of decamethonium- 
like action and that results from it can be 
transferred to other tissues). Thus if the 
ratio is greater than one, the compound may be 
(but need not necessarily be) acting like 
decamethonium, whereas if the ratio is less 
than one, the compound is in all probability 
not acting like decamethonium but rather like 
the BTE compounds. 
If these conclusions are correct and the 
longer members of the BTM series are not acting 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































compare these with a compound such as BTE 16 
rather than with a standard within their own 
series. 
The longer BTE compounds i.e. those 
unlikely to be acting like BTM 10 are more 
active than the analogous BTM compounds and 
indeed BTE 16 appears to be about 8 times 
as active as ( +)- tubocurarine and 2 times as 
active as decamethonium on the cat (if a 
comparison between these two differently acting 
drugs has any meaning). It is extremely 
interesting that activity in the BTM series 
increases again after declining in the region 
of BTM 12 - 14. This pattern of activity is 
not what would be expected from extrapolation 
of the results of Paton and Zaimis (1949) 
obtained with BTM 12 and 18, but it is consistent 
with all the work with the compounds of the 
BTE series. For the longer compounds there 
is very little difference in the variation of 
activity with chain length in the two series, 
with the exception that the maximum in activity 
occurs at a slightly shorter chain length in 
the BTE series (BTE 16 - 17) than in the BTM 
series (BTM 18). 
127. 
The correctness of the results obtained in 
this work is to some extent borne out by the 
experiments with the compounds in which the methyl 
groups in BTM 16 are replaced by ethyl groups. 
The activity increases with increase in the 
number of groups replaced. 
The likelihood that the pattern of activity 
for the longer members of the BTM series is 
genuine and that the shorter, decamethonium -like 
members are the unusual ones is further supported 
by the results on the ganglion. At this site 
there is practically no difference in the 
variation of activity with chain length in the 
two series (Tablel6B, Graph) except that again 
the maximum in activity occurs at a slightly 
longer chain length in the BTM series (BTM 18) 
than in the BTE series (BTE 17). Also BTE 16 
and BTM 16 are almost equal in activity, and 
the two intermediate compounds, as ethyl groups 
are replaced by methyl, have very similar 
activities too. Probably the slight differences 
in activity between the four compounds, 
particularly as the 'mixed' compounds appear to 
be slightly less active than either BTE 16 or 
BTM 16, are covered by the limits of experimental 
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128. 
Variation of Activity with Chain Length 
The picture that emerges from this work is 
that of series of compounds which have marked 
affinity for the acetylcholine receptors in both 
ganglia and the neuromuscular junction. A 
few results obtained by Warriner (1960) on the 
rat ileum and in the present work on the guinea - 
pig ileum suggest that the longer members of 
the BTE series at least may also have considerable 
affinity for muscarinic receptors - atropine - 
like activity was obtained with BTE 16 - 18 at 
about 1 x 10-7M, the activity having increased 
steadily to this level. Paton and Zaimis (1919) 
did not think that the BTM series possessed any 
remarkable atropine -like activity, but it may be 
that the higher members in this series, which 
they did not test, are also active. The 
action of these compounds at all these acetyl- 
choline receptors appears to be purely 
antagonistic (with the exception of the compounds 
closely related to BTM 10) and though it might 
be expected that the antagonism is competitive 
it has never actually been adequately tested. 
This is something which should be done. The 
affinity of the compounds, which leads to their 
129. 
antagonist activity, seems to be fairly non- 
specific for all acetylcholine receptors, 
unlike that of some other compounds which are 
only active at one site. 
In a study of the action of shorter BTM 
compounds and also of alkyltrimethylammonium 
salts on acetyicholinesterase, Bergmann and 
Segal (1954) observed a logarithmic increase 
in affinity of the alkyltrimethylammonium salts. 
They suggested that this might be due to a step- 
wise increase in free energy change on adsorption 
of the methylene chain on the protein surface, 
and calculated that the free energy change was 
about 300 cals. per methylene group. For the 
BTM compounds, the increase was less regular but 
was comparable over part of the series. A 
similar situation appears to be observed with 
the longer bis -onium compounds at the receptors 
in the ganglia and the neuromuscular junction. 
At the ganglion for instance between BTE 11 and 
BTE 16 and between BTM 12 and BTM 16 the 
activity increases more or less in a geometrical 
progression. At the neuromuscular junction the 
same holds for the compounds from BTE 11 to 
BTE 15 (Table 16). It might be speculated 
therefore that the bis -onium compounds combine 
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with the acetylcholine receptors by virtue 
of their charged ammonium group, and that 
the increase in affinity and hence in antagonist 
activity with increase in chain length is due 
to the adsorption of each additional methylene 
group on the receptor protein or adjacent 
protein surface. Ability to act as an 
antagonist might depend only on the bulk of the 
molecule, whereas agonist activity requires a 
thin molecule whose chain -length is within 
certain limits. 
The reason for the decline in activity 
above BTE 17 and BTM 18 is not known though it 
could well be that it is associated with the 
increase in the surface activity of the compounds. 
The activity is not likely to be limited by 
micelle formation but may be limited by some 
additional surface effect on the cells. It is 
even possible that the activity may be limited 
by the sheer bulk of these molecules. After 
all, the dimensions of the synaptic cleft at 
the neuromuscular junction appear to be of the 
order of 300 A and these longest compounds are 
between 30 and 35 11 in length when extended. 
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